Clinical

EH
case-control_design


adverse events
tertiary referral centre
NO production_of EC

molecular mechanism
dXA
FM
exercise cardiovascular_health
HF
devices heart_ failure
Liver_ disease
Renal artery stenosis
inhospital_ mortality
Retrospective cohort study
surgery heart transplant recipients
heart_ failure Latin America
Observational_cohort
period_ breathing heart beat
Retrospective cohort

HF
90-day mortality


trial


doctors
Heart rate
nutrition heart failure
Northwest_United States
heart failure
surgery
cross-sectional
INTERventions
unilateral
Heart failure


clin
trans
Sci
secondary
Intermediate_ frailty
randomised studies
CHF
dodson

exercise_ modality

temporal_trends
rates risk factors CHF
Heart_ failure
Patients
air pollution heart_ failure
extracorporeal
cardiovascular_ disease
Heart_ failure
hatasis
ischemic_ conditioning heart_ failure
Heart rate_ variability risk_ stratification cardiac_ patients
Retrospective matched_cohort


policy


Sham-operated_animal control group
retrospective descriptive_design
taxonomy
HF
exercise cardiovascular system
reporting Cell Anand
study-related adverse events

doxorubicin
doctors transfusions
Heart_ failure bisphosphonates
diuretic heart_ failure outcomes
Caspase_ gene expression heart_ failure
cox proportional_ hazards
right_heart_ failure pulmonary hypertension
european HF
hypertension
genes
Literature
internal_ reliability cronbach
trials
patient_ safety

implanted monitoring_ devices
few treatments clinical trials
HR afterload_ burden
periprocedural strokes
RAS atherosclerosis
frailty heart_ failure community
PSSS exercise_training
MicroRNAs heart_ failure disease
exercise heart_ failure
cox regression
Cardiology bromodomain inhibition_ halts heart_ failure
management heart_ failure preserved ejection_fraction
median_âge
inpatient medical conditions
Jehovah_s Witness severe anemia
department_of_cardiology university_hospital
HFpEF
HF
autonomic balance
impact_of_frailty HF


Heart_ failure cognitive_ impairment mortality
LV_ fibrosis ANS
median follow-up_ duration
competitive collateral
Indices CO mixed linear models
heart failure_hospitalization cardiovascular_ death
cognitive_function quality
vasopressin congestive_heart_ failure
cardiac_ transplantation
Mitral_ stenosis reversed medical_ treatment heart_ failure
pde2 HF

propensity score-matched

black

metric_ choice readmission_ metrics
ET exerts beneficial_effect CHF
readmission_metric
physician_ volume
residual confounding short follow-up
median follow-up
arrhythmia-related costs
Medication sST2 values

sts_HM
systematic_review network meta-analysis
surgical_ tactics hypothermic_ circulatory arrest
functional_capacity quality
mortality random-effects models
ejection_fraction bNP

Chronic_HF
etiology MR
HFpEF
Cardiac_amyloidosis
Pigs antiarrhythmic_ medication sudden death
robot-assisted_training heart_ failure

CHF

Heart rate arterial_ pressure
therapy beta_blockade
hgb baseline_HRQoL
cardiac inflammatory_biomarkers
systolic_ dysfunction
preserved ejection fraction outcomes trial
cardiovascular_hospitalization
biomarkers chronic_heart_ failure
heart_ failure emergency_ department volume
VO2max statistical


HR HF
research biomarkers

prognostic_factor

clinical trials

abnormal_ cardiac_T2
trials

interventions
risk
Heart_ failure left_ ventricular_ejection_fraction
quality_of_life
cox proportional_ hazards
Tolvaptan vasopressin receptor antagonist
Epidemiology chronic_heart_ failure bisoprolol
spironolactone systolic_heart_ failure
Heart_ failure_HF
Functional_ MS degenerative MR
eRK1/2 molecular_ scaffolds heart_pathology
cornerstone_of_heart_ failureHF_therapy
lVET aortic_ pressure_ curve
Cardiac congenital_lesions
nights hospital
Trastuzumab-related cardiotoxicity breast_cancer
public_health_problem
physician continuity discharge
postoperative_normalization albumin level
prognosis pathophysiological

patients heart_ failure
gross income health per capita
AHA ESC advocate pre-participation_ screening
data examining long-term outcomes
clinician_expert HF
diagnostic_ devices HF
intervention adherence cPGs
enrollment




insignificant MS
cox proportional_ hazards
dialysis device implantation
self-Care_of_heart_failure_index
risk_of_heart_ failure cox proportional_ hazard
endothelial flow-mediated dilatation
acute kidney_ injury
Pharmacology acute_heart_ failure
postoperatively multiorgan failure sepsis
Nordic_ walking
baseline heart_ failure
survival_projections Seattle Heart_ Failure_model
Hemodynamic_ phenotype failing_ Fontan adult_ population
MS echocardiography
Coronary_ angiography


off-pump sternal_ sparing_ approach HeartMate_II exchange
adverse events
QRs duration
race exercise
nursing_ terminologies

median follow-up

deficits

gLS


anaerobic_ threshold heart_ failure
renin-angiotensin-aldosterone_system inhibitors heart_ failure
CHF unilateral renal_ DNx cardiac_ autonomic balance
skeletal_ muscle_ abnormalities exercise_capacity Fontan circulation
acute_heart_ failure_ trials
chronic_ kidney_ diseaseCKD
mitral_regurgitation HF
progressive hypertension kidney_ failure
treatment end stage_heart_ failure
hospital heart_ failure discharge
systolic_HF

oUTC_measures readmissions
abnormal_HR_ variability sudden non-sudden cardiac_ death
toxicity systemic_ blood pressure
medication resting_hemodynamics
Physician_ volume
postystolic_function
Mice aac progressive_development cardiac_ hypertrophy
patient_ satisfaction sustainability intervention
economic_ savings cost
ICU_ mortality
Nurses
cRT dialysis-dependent
CHF

HF
Hypoalbuminemia
angiotensin_ receptor neprilysin_ inhibitor heart_ failure
cardiac_sodium_ current systolic_heart_ failure
diastolic_ dysfunction peripheral_ artery disease
Western blot_analyse immunohistochemistry electron_microscopy
idiopathic dilated_ cardiomyopathy
ischemic_ cardiomyopathy male_ sex
hypertensive_ LV dysfunction mild MR MS
HF chromatin_ hyperacetylation
physicians HF
race spironolactone severe_heart_ failure
sinus_rhythm AF
ingenuity_pathway
heart_ failure cardiac_rehabilittion
cd HF etiologies
Myocardial_infarction adult male Wistar rats

anemia
acute_heart_ failure
reporting
care_management telehealth medicare
preoperative_ demographics operative outcomes survival
post-LVAD_AI

Rhythm- rate-control
rehospitalization
proteins TAC
MS

Mediterranean DASh_diet_ scores food-frequency
social_support exercise
diabetes EO-CFUs
risk_strategy hospitalization heart failure_ clinic outpatients
Cardiac-resynchronization_therapy heart_ failure
hospital readmission_reduction_program congestive_heart_ failure
Blacks lower peak VO2 baseline
odds_ratios hospital clustering
HFrEF HFpEF
nitroxyl acute_of_heart_ failure
physician_ continuity urgent_ readmission discharge patients heart_ failure
Heart_ block pulmonary_ artery_ snared biVP
recruitment intervention compliance attrition
resistin inflammation metabolism heart_مرض
cardiovascular_events
LVET admission follow-up measurement outcome
Bioinformatic microarray_data
CAD systolic_HF
diuretic_ use HF

af patients echocardiographic_ examination

congenital_heart_Lesions
PVF PB
sST2_ concentrations BB_therapy
Cardiac pressure-volume_ conductance_ catheter_system
MS
beta-blockers adherence
safety_ end_point procedure adverse neurological cardiovascular events
holosystolic_ murmur third heart_sound
heart_ transplantation left ventricular_assistance
right ventricular_function body_ composition
haemodynamic neuronal stressors
subclinical_atherosclerosis general_models
exercise_intolerance chronic_heart_ failure
preoperative hypoalbuminemia lVAD
coronary_ заболевания heart_ failure
clinical_studies elevated_ resistin_ levels severity heart_ failure
deficit_index biological_ phenotype mortality
atrial_fibrillation_AF heart_ failure
cachexia right_ ventricle heart_ failure
signalling_pathways maladaptive cardiac_ remodelling
baseline electrocardiographers
AVd VVD free_wall_RS
heart_ratio
incidence ESRD outpatients HF
branch_ block electrical_activation_sequence
hHF dPP-4 inhibitors
ECCT advanced_heart_ failure_therapy
CV death non-fatal_ stroke hospitalisation heart_ failure
exercise_training endothelial_function
heart_ transplant ECCT
ffffff_of_theory body_weight CC
periprocedural dialysis
precipitating_factor clinical_ deterioration HFPEF
multihospital_ study heart failure_ guidelines nurse leaders
Southeastern Minnesota HF
Cardiac_ cachexia body
Frailty risk_of_HF
proteome HDL_particles shotgun LC-MS
Fatal nonfatal_ outcomes
preoperative_ clinical_ characteristics laboratory_ variable mortality
cardiac_pathogenes
mortality iCD-HF
extubated blood loss transfusion
septal defects surgical
discharge follow-up medication
heart_ failure_care
bromodomain proteins
mortality_rate
bTT DT
hypotension
pharmaceutically

biomarkers HF
Peak_vo2
ST2 evaluable plasma

quality_mechanism
trastuzumab-related_ CHF
patients transplants
aerobic_ exercise
ranked hospitals


HF hospital admissions transplant ventricular_assist device
Coronary_ artery_ disease_CAD systolic_heart_ failureHF
Heart_ failure rheumatoid_arthritis TNF_ antagonist
Renal_ artery_ stenosis RAS peripheral_ arterial_مرض
Wilcoxon signed-rank_test pre-post_ comparisons
left ventricular_assist device right ventricular_support
psoriasis atherosclerosis incident_ cardiovascular_ events Rotterdam

data
eplerenone primary composite_ endpoint
Orthotopic_heart_ transplantation oHT end-stage_heart_ failure
right_atrial_myxoma pulmonary_ embolism right_heart_ failure
Unilateral renal_ denervation autonomic_ balance conscious rabbits chronic_heart_ failure
Myxomas pulmonary_ arterial_vasculature
high-risk_patient heart_ failure reduced ejection_fraction
Nfat miR-25 transcription_factor Hand2 heart_ failure
regulatory_ subunit HF
coronary_heart_ disease stroke heart_ failure
VEGF_ inhibition b cardiac_function remodeling
β-blocker sST2
readmissions heart_ failure_ readmission_quality

Pediatric_heart_ failure_HF morbidity mortality
resistin decline ejection_fraction
heart_ failure medication
ECCT cardiac_ transplant recipients
cPET_ guiding_ exercise_ rehabilitation CHF
prescribing guideline-recommended_ medications heart_ failure
Heart_ failure_HF cardiovascular_hospitalization
malfunctioning HeartMate_II_LVADs

Renal_ DNx circulating_ plasma CHF-INV rabbits
EH HFpEF
pump_ failure driveline_ injury isolated pump_ replacement
evidence-based_therapies
hHF saxagliptin sitagliptin
band_of_activated Caspase paced myocardium
ischemic_inflammatory abdominal_problems MT
renal_disfunction post-transplant_ morbidity
MedLine EMBASE cINAHL
aCR CMS_ metrics
HF
anemia heart_ disease
survival hospital_discharge
Heart failure_management_programs medical resource
HDL-bound malondialdehyde HDL-induced_no production EC
median HF
NP_ assessment ED
trastuzumab
lVAD_ implantation
pre-HCT germline_DNA genotype
clinical_症状

derivation_cohort CAD
blood work_ drawn medication
cPCs functional_capacitypeak VO2
bottleneck_ stent_model chronic myocardial_ischemia heart_ failure pigs
Gastrointestinal_ bleeding ventricular_assist devices cardiac_ nurse
LV filling_ pressure severe systolic HF
exercise adverse_ events coronary_ artery_疾患CAD
remote hospital discharge patients heart_ failure network meta-analysis
Soluble_ ST2 ambulatory_ patients heart_ failure
Cardiac Mammalian Mena heart_ failure mice
Titin hypophosphorylation myocardial_DD
baseline echocardiogram reverse_ remodeling
LVAS bridge to transplantation destination therapy
apoptosis canine_model chronic_heart_ failure tachycardia
concentrations_of_soluble sst2
RAS- β-blocker uptitration HFpEF
Framingham_ Heart_ Study HF EF
guideline aCP clinical_practice guidelines
diuretics congestive_ symptoms heart_ failureHF
ED intubations congestive_heart_ failure
east rhythm_control_therapy cardiovascular_ complications AF
Cardiac_ hypertrophy energy metabolism
radiological_ signs HF
Nicorandil doxorubicin
risk_of_heart_ failure aging body
Heart_T2
osprey networks
HRQoL baseline Hgb
NOc outcomes admission_discharge
AF-free_ probability catheter ablation maintenance sinus_rhythm
paediatric_ cardiac_ transplants
inpatient records HF
iCD-HF
pneumonia surgical conditions
Patients cardiovascular
laboratory_report_model aRIC_HF
device_ implantation cRT


clinical change
deficit_index
Medicare post-acute_care_transfer policy
QRS
ED_ visits CHF
nutrition_elements vegetables whole grain_intake mortality

groups internal_ consistency test-retest reliability
iron
right ventricular_contractile_ reserve pulmonary_ hypertension
QT intervals SDQT
emergency cardiac_ catheterization extubated intermediate_care
exercise_training chronic_heart_ failure high-density_ lipoprotein
resistin acute anthracycline-induced cardiotoxicity
BAT sympathetic_outflow parasympathetic activity
t1_mapping myocardial_ fibrosis
acute autonomic_system_modulation QTV HF
Heart_ratio aortic_ blood flow doxorubicin
RVPO biVP RS synchrony CS
cardiac resynchronization_therapy dialysis-dependent_ patients heart_ failure
cardiovascular_ смерти HF_hospitalization exercise_training lower_btes
skeletal_ muscle_mas correlated poorer VO2 max
ees ventricular-arterial coupling SV
double-blind active_ treatment placebo
Myocardial_pde2 expression HF
diastolic_ failure cardiomyopathic_ restriction flow
hospitalisations readmissions mortality
psychosocial_factor exercise_training heart_ failureHF
autonomic_system_activity QTV
pump malfunctions pump_thrombosis hemolysis
atrial_fibrillation pacemaker
body_index cRF treadmill_ exercise
human myocardial_ tissue pKA subunits
electronic_ databases world_health_organisation HF
compliance exercise injections

cardiac_ stress antagonizing β-AR drive
ethics_ Rounds
PSSS social_support
bisoprolol
Frailty
ED_ visits CHF intubation_ rates
physician_ continuity
Medicare fee-for-service hospitalizations
clinical therapeutic
high-risk
exercise_ attendance diet adherence

parallel-group single-cohort_ study hypothetical
renal DNx cardiac_ autonomic balance CHF sympathetic_ tone
anemia clinical_practice_ guideline American College_of_ Physicians
end-stage renal_ disease outpatients systolic_heart_ failure
parasympathetic_ neurotransmission acetylcholinesterase inhibition
heart_ratio ivabradine left_ ventricle heart_ failure
Heart_failure Pathophysiology medical_ Treatment_guidelines Nursing Management
medical_management_of_heart_ failure_of_children Canadian Cardiovascular_ Society guidelines
neurohormonal stimulation inflammation endothelial dysfunction
echocardiographic reverse_ remodeling cardiac resynchronization_therapy
Neurohormonal_abnormalities pathophysiology congestive_heart_ failure
miRNAs heart_ failure
RV_disfunction weight_ratio
morbidity_ mortality
cardiopulmonary_ exercise_ variables
potent_ inhibition L-type_ca2_ currents Rad_variant congestive_heart_ failure
radiological_ signs HF
right ventricle normal cardiac_function medical
Jehovah's_ Witness sickle_cell_ disease life-threatening anemia

congestive_heart_ failureCHF

chromatin_ subproteome diseased mouse_heart
muscle-wasting_ syndrome acquired_heart_ failure Fontan
Mediterranean DASh_ diet_ scores mortality heart_ failure
LVEF long-term_ mortality
ctnt NT-probNP HF_risk_predion
inhospital_ mortality median bNP_level
health_ Buddy_program ED hospitalized
resistin_ levels anthracycline-treated breast_cancer cardiotoxicity
health Buddy_program content-driven telehealth_system care
Mortality
contemporary_therapeutic_ options
dobutamine furosemide_ dose oxygen_ flow
differential_ relations cPCs diabetes


diagnostic procedures
Thirty-day_ mortality
futility data safety_board
acute RV_ failure left_ ventricular_ dysfunction
Left_ ventricular_ ejection acute_heart_ failure precapillary_ pulmonary_ hypertension
aortic_valve_insufficiency left ventricular_assistance
ejection_fraction cardiac_ resynchronization_therapy mild_heart_ failure
biventricular_pacing left_heart twist_ strain porcine_model right_heart_ failure
myocardial_diastolic_ dysfunction collagen deposition titin
Stress doppler_echocardiography pulmonary_ hypertension
septal_wall_ CS free_wall VVD
inhibition protein_ kinase soluble_ guanylate_ cyclase contractile_ response
adverse_ events death_ transplantation circulatory_assist device
systolic diastolic_ mitral_leaflet_ motions clear organic_lesion
circulating_progenitor_cells outcome heart_ failure
sympathetic activity i-MIBG myocardial washout
student t_test cis regression
pulmonary_ artery
proof-of-principle_cohort
HR_reduction beta_blockers exercise_capacitation
LV strain_ratio echocardiography baseline ablation
serial_ measurements cPCs functional_capacity heart_ failureHF
pressure_ ulcers surgical_ patients
clinical echocardiographic invasive_hemodynamic
CHF atrial_explants c-Kit_cells sham_ explants
bundle-branch_ blockLBBB non-LBBB
cardiac_Mena deletion cardiac_disfunction conduction abnormalities hypertrophy
refractory end-stage congestive_heart_ failure
beta_blockers heart_ failure
economic_impact
trastuzumab cardiac_comrbidities
perioperative
HF valve plasty MS mVA
demographics insurance_status comorbidities

baseline ST2 level interquartile
human resistin chemotherapy-induced heart_ failure humanized male_mice breast_cancer
_efficacy_ outcomes composite_of_ death

therapeutic_functions fluid_overload
Nursing-sensitive outcome_ change_ scores hospitalized older_adult heart_ failure
test-retest_retest_retest_ reliability Timed up_go test patients advanced_organ_ failure
black_race mortality
transcatheter
chelation_ regimens heart iron
social_support barriers exercise adherence clinical outcomes
Chinese_ herbal_medicine dilated_ cardiomyopathy heart_ failure
implantable cardioverter-defibrillator_deactivation
protein_ levels Western blot DNA_ fragmentation TUNEL autopsy
Heart_of_ mortality western_ society cardiovascular_ заболеванияs
HFPEF dietary sodium restriction ventricular vascular_ stiffness
EH cardiac_ filling_ pressures
electromechanical_delay dyssynchronous_heart_ failure computational
apoptosis pacing-induced_ dilated_ cardiomyopathy
chronic_heart_ failure_CHF sympathetic_ tone autonomic_ imbalance
right_atrium_ mass prolapse tricuspid_ valve stenotic_ physiology
functional_capacity
Fontan_ failure systolic_ ventricular_function liver_مرض
Western blots monoclonal_antibodies Ser83 phosphorylation HF
cardiac_ catheterization thrombotic_ obstruction right coronary artery
preoperative serum albumin_levels left ventricular_assistance
magnetically_ Levitated Left_ Ventricular_assist_system Treating Advanced HF
cost-effective
study closure
cardiac_ nurses
consultations procedures
transfusion_ thresholds mortality
risk_of_heart_ failure exposed group control
concordance_ c statistics UM/VA/VA-RT
neurological cardiovascular_event-free_rate
BETs mouse TAC human HF
Czech_ Republic
chemical instability cogeneration nitrite vascular
MAD-CRT device
HF
dopamine nesiritide
Extracorporeal_ membrane_ oxygenation infarction-related refractory right_heart_ failure
office_of_statewide_health_planning_and_development Patient_discharge
LV dilatation functional MS
treatment HRQoL
inotropic_effect beta_blockers treatment heart_ failure
echocardiography shunt_ implantation
energy metabolism hypertrophied_heart
resource_ use quality_of_life time-varying Seattle Heart_failure
anticoagulation underlying_heart_ disease rate
ED physicians suburban_hospitals New Jersey
pathophysiology HF medical management nursing
Paco2 cerebral_ blood flow carotid_ bodies
baseline mechanical_ cardiac_support renal_function
human_heart_ failure altered protein_ kinase subunit expression post-translational_state
ECmo_group VAD ECmo+VAD
cox regression cardiovascular_ events psoriasis
PAD ankle-brachial index
hospitalisations sTS
Isolated HR reduction ivabradine TAC
implementation_conventions class_I CPG recommendations HF
mortality cancers health-care budget
NT-probNP circulation HF
patients preserved systolic_function therapeutic
HDL-induced NO production flow-mediated_dilatation
cutoff_level NT-probNP
patients aHF

HF cohort
studies iCD
computing_ readmissions hospital_ ranking pay-for-performance
nontreatment
cox_models
exercise intolerance_intolerance heart_ failure
psoriasis
bNP NT-probNP
functional MS ring_ annuloplasty ischemic MR LV dilatation
vasopressin_ receptor_ antagonist tolvaptan
pro-adrenomedullinMR-proADM FFM
interleukin_ receptor_ family member ST2 beta-blocker_therapy
New York_heart_association
ventricular_assist device extracorporeal_ membrane_ oxygenation pediatric_heart_ failure
Cardiorespiratory_ fitness body mass_ index heart_ failure_ mortality Cooper_center
TUG_test advanced_ COPD CHF cRF
physical_activity cardiovascular_risk_factor diabetes mellitus hypertension hyperlipidaemia
isoproterenol cXL-1020 myocytes failing hearts
HF spontaneous VT beat-to-beat QT
heart_ failure systolic_heart failure
biventricular_ dysfunction isolated HeartMate II
HF cardiac_ murmurs reduction blood_ pressure
Functional MS medical treatment surgical
management ventricular_assist devices device therapies
renal_disfunction mechanical_ cardiac
device
enrollment left_ ventricular_dilatation dysfunction
PB PB HF
anemia patients heart_ disease
CF_LVAD_ patients AI heart_ failure
social mandate
TREatment hemodynamically_ unstable
exploratory_factor_analyse cfa
rhythm-control rate-control
Heart_ failure_HF

study_design hemoglobin_level health
HF epidemiology health_services HF
serum_ factors coagulability
hospital length_of_ stay rehospitalization
sudden_ cardiac_ смерти
composite_ measure
administration trastuzumab-related CHF
long-term_ survival
hospitals
research_studies biomarker-guided clinical trials
medical_ records

cardiac_ angiogenesis in vivo_ coronary_perfusion cardiac fibrosis
heart_ failure hapEF
Circulating N-terminal pro-B-type natriuretic_peptides plasma_of_heart_ failure
Pyridostigmine myocyte collagen_ density surviving left_ ventricle
ejection_fraction infarct_ size collateral_ growth myocardial_perfusion
Heart_ failure_HF
atrial_fibrillation congestive_heart_ failure rhythm-control rate-control
end-stage_heart_ failure long-term_wind_assistance_ device
ATP_ demand XO-mediated ROS mitochondrial_ respiration contractile
adenyl_ cyclase differential_G-protein coupling
predictors_of_ mortality implantable_ cardiac_defibrillator
exercise_intolerance chronic_ HFPEF reduced quality_of_lifeQOL
signaling_pathways pressure-overload-induced_heart_ failure
autonomic_modulation repolarization_instability heart_ failure prone ventricular_tachycardia
systolic HF unclear_ etiology coronary angiography
SCHfi clinical_practice
energy substrate metabolism isolated working_hearts aAC
diabetes mellitus cardiovascular_مرض
parasympathetic_function slow HF evolution
HFpEF adverse_ outcomes
surgical_revascularization catheter-based_revascularization
HR tNF_ antagonists nbDMARD
risk_of_ incident CVd psoriasis
high_bNP_ levels PAD routine_bNP_ measurements HF
Morpholino-based_ knockdown_of nucleoline abolished protein_ expression gross morphological
clinical_predion rule CAD systolic_HF
population-based Rotterdam_ Study psoriasis cardiovascular outcomes
cognitive_ impairment 6-month_ mortality
race exercise_training ambulatory HF
baseline_hgb exercise_training kccq subscales
sonographic histological gastrointestinal_regions
acs procedures MT VAD
general_hospital cardiac_specialty_hospital
haemodynamic pulmonary peripheral abnormalities
ECmo eGFR
HF-related cachexia RV body composition

diagnostic_ rule
acute_HF
Heart_ failure_HF
pump-exchange_techniek redo sternotomy cardiopulmonary_ bypass
aggressive medical_治療 HF HF MS
sympathetic parasympathetic_activity HF
medical HF
mouse HF_model compensated LV_ hypertrophy HF hHD
chronic_meocardial_ischemia heart_ failure
Spironolactone hyperkalemia acute kidney
EH renal impairment hypertension
jugular venous_ pressure peripheral_ oedema volume
natriuretic_peptide biomarkers point_of_care
mechanical cardiac_support renal_function end-stage_heart_ failure
anticoagulants antiplatelet_ drugs treating heart_ failure atrial_fibrillation
functional mitral_ stenosis ring_ annuloplasty ischemic_ mitral regurgitation
heart_plantationsLV_assist_ device_ implantations heart_fail admissions
heart_ failure preserved_ejection_fraction clinical_doppler_echocardiography
national patient_ safety_initiatives
clinical_care maladaptive_ molecular_processes
long-term costs survival
early-onset MI HF
HF-induced_ remodeling EMD prolongation
cardiovascular_ conditions HF
sustainability commissioning hospital- community-based programmes
practices evidence-based_practices
isolated HeartMate_II_LVAD
normalization albumin_ levels postoperative_ survival
Raf-MEK1/2-ERk1/2 signalling_pathway maladaptive remodelling
hereditary congenital_ abnormalities heart nontraumatic_ death
health_system_data partners u.s Food_drug_administration Mini-Sentinel
Bisphosphonate heart_ failure
left ventricular_ longitudinal_ systolic_ strain cardiovascular_ events atrial_fibrillation
Xanthine oxidase_ inhibition left ventricular_ systolic diastolic cardiac_ volume
immunodetection NT-probNP antibodies terminal_regions
PD clinical status hospitalizations therapy severe end-stage HF
spironolactone systolic_heart_ failure
Nordic_walk cardiac_rehabilittion_care
aortic_valve_ surgery new-onset post-LVAD AI
medications heart_ failure NCDR PINNACLE
Heart_ failure atheromatous_ coronary_ disease
HFpEF fatigue fluid retention
diagnostic_test HFpEF
unloading_of_the_heart isolated_HR_reduction systolic_heart_ failure
network Cytoscape
circulating mediator insulin resistance human monocytes inflammatory stimuli
blacks hypertension diabetes ischemic_ etiology whites
predictive_ cutoff_value NT-probNP_test long-term_ survival ED_patient acute_heart failure
oxidative_ stress GTPase_ Rac1 hearts ANS mice
Heart_of_HF
figures right_heart_ circulation
Fontan_ circulation_ exhibit skeletal_肌肉 mass metabolic abnormalities
hypothesis-generating_ findings mineralocorticoid_ receptor_ antagonists race
failing Fontan_ circulation cardiac_index pediatric_cohort
HF_hospitalization cRThazard
palliative_care patients advanced_مرض therapeutic
rehospitalization medicare fee-for-service_ beneficiaries skilled_nursing
isolated_LVAD biventricular
trial control_group

cardiovascular_ смерти urgent_ cardiac_ transplant
clinical_prognostic_diastolic_ dysfunction HFPEF
HF preserved_ejection_fractionHFpEF hypertension
myocardial_ischemic_ events cardiac resynchronization therapy
parasympathetic_ tone pyridostigmine ventricular_ dysfunction heart_ failure
NT-probNP HF patient_ plasma immunoprecipitation mass spectrometric
β-Blockade cardiac_ angiogenesis heart_ failure VEGF signaling_pathway
NYHA functional_class quality-of-life_ score hall walk
Chromatin-associated_ proteins chromatin_structure DNA gene expression profile
heart_failure_adherence retention_TrialHART
nonselective beta-blockers cardiac_ sympathetic_activity hemostasis heart_ failure
right ventricle overload stroke_ volume left ventricular_ejection_ time
Myocardial_infarction left anterior_ descending coronary_ artery occlusion
β-Adrenergic_ receptor_ blockade hospitalizations heart_ failureHF

reduction 30-day_ readmission_ rate
psoriasis systemic_UV_ treatment
stress conditions maladaptive_ remodelling heart failure
mortality LCX LAD two-vessel_ disease
pPR aCR CMS
Intravenous iron heart_ failure iron_deficiency
RV_ dysfunction weight_ loss abnormal_ body_ composition
LVET_at entry ICU
non-ischemic ischemic
exertion abnormal exercise hemodynamic
robot-assisted_ gait_therapy Lokomat_system heart_ failure
CHF_ patients emergency_ department
gut inflammation dietary_interventions heart_ failure
heart_ failure Emergency_ DepartmentED ED_ volume patient outcomes
congestive_heart_ failure
mitochondrial_structures sarcomeric_microstructure
ET CHF-NYHA-IIIb HDL_function
early physician_ follow-up_discharge
CHF therapeutic_ interruption activated_ neurohormonal systems
uptitration heart rate renal_function spironolactone
microRNAs_miRNAs progression_of heart_ failure
aim implantable_defibrillator_deactivation
pulmonary_ hypertensionPH heart_ failure
consenting ambulatory HF
Beta-blocker_ dose resting_HR
QT_ variability QTV repolarization_lability QTV risk_predor sudden_ cardiac_ death
practice-level_of_care heart_ failure reduced ejection_fraction
dialysis adverse_ events echocardiographic
mutant_mice overexpressing Hand2 heart_ muscle_cells pathological_ hypertrophy
white_ rabbits renal DNx pacing-induced CHF
catheter ablation antiarrhythmic drugs rhythm_control therapy
processes_of_care_ delivery
RAS-blocker uptitration clinical_ outcome HFpEF
Cardiac_ failure diabetes diabetes heart_ failure
transoesophageal_echocardiography shunts thrombosis migration
arterial_ tonometry lVET_carries precapillary_ PH heart_ failure
paraDIGm-HF chronic_heart_ failure Chronic_heart_ failure cardiology
Hemoglobin health status patients chronic_heart_ failure HF-ACTION randomized_controlled_ trial
ZSF1 rats heart_ failure preserved ejection_fraction
cross-talk heart adipose_ tissue cachectic_heart_ failure body
systems proteomics cardiac_ chromatin nucleolin regulator_of_ growth cardiomyocytes
cardiac_disfunction subcellular_ alterations metoprolol heart_ failure myocardial_infarction
t1-mapping mRI tidal_ respiration myocardial_ T1 swine heart_ failure
Myocardial collagen collagen titin isoforms phosphorylation
heart magnetic_ resonance_ imaging chelation_ choices risk thalassaemia
LV_diastolic_disfunction filling_ pressures doppler_echocardiography
Cardiac_ magnetic_ resonance postcontrast_ T1 time heart_ failure preserved ejection_fraction
internal_ external_ validity costs clinical_ trials
proteins
inappropriate_therapy
Rhythm_control_therapy
medical_management HF infancy adolescence
familiar physician index admission
Plasma HF
cardiovascular_مرض baseline
hospital_composite AMI_ mortality

quality_of_care_programme guideline-recommended beta-blocker_therapy
acs oHT bridged transplant MT VAD
psoriasis risk_factor cardiovascular_ diseaseCVD
cutoff negative_predive_value e/e'septal negative_likelihood_ratio
hospital_rate HF CMS_metric
patients dRS_ deciles
pde2-overexpressing cardiomyocytes norepinephrine-induced hypertrophic
frailty risk_of_heart_ failure
baseline
heart failure bisphosphonates
GDMT BAT
RAS- β-blocker_ dose
expression Bax bcl-2 proteins
miRNAs cardiac_ remodeling heart_ failure
alendronate risk_of_heart_ failure
risk_of_heart_ failure CLCNKA sNP
regulation_of feeding nutritional anti-inflammatory_effects CHF
clinical_diastolic_ dysfunction
transduction_pathways signalling_ proteins
recurrent HF rheumatoid_arthritisRA
AlphaLISa immunoassays NT-proBNP
β-Blocker-induced cardiac_ angiogenesis cardiac_function remodeling
symptomatic_adult_ Fontan_SAF
ambulatory ICD_ patients predictor mortality multivariable regression
fes preserved_ejection_fractionHFpEF
cardiotoxicity doxorubicin anti-neoplastic_agent
MT VAD_group aCS operations high mortality morbidity
physician_discharge physician_ continuity patients heart_ failure
sinus rhythm antiplatelet_agent anticoagulants efficacy
c-statistics biological_ phenotype deficit_index
heart_ failure preserved left_ ventricularLV ejection_fraction
nicorandil cytotoxic_effect doxorubicin solid Ehrlich_ carcinoma
implantable cardioverter-defibrillator_deactivation
Renal_ denervation CHF
LV_diastolic_ dysfunction HFPEF
natriuretic_peptides emergency ambulatory
Myxomas cardiac_ benign_ tumors left_atrium right_atrium
life saving_drug HF_ejection_fractionHFrEF
lean zSF1_group hypertensive obese ZSF1_group hypertensive diabetic
Gastrointestinal_ bleeding ventricular_assist devices
severe hyperkalemia acute kidney_ injury spironolactone clinical_ trials
heart_ failure elevated left_atrial_ pressure
diagnostic_ roles bNP NT-proBNP coronary_ artery_مرضCAD
myocardial_pDE2 intracellular antiadrenergic_strategi HF
heart failure-related_hospitalization patients preserved left_velocular_ejection_fraction
shortened_lVET ICU admission precapillary_PH heart_ failure
Mammalian_ enabled_Mena cytoskeletal_ actin_ dynamics heart_ failure
refractory_congestive_heart_ failure peritoneal_dialysis
Heart_ failure preserved_ejection_fraction HFPEF cardiovascular_ reserve
heart_ failure preserved_ejection_fraction HFPEF
Functional_ mitral_ stenosis m ring_ annuloplasty ischemic_ mitral regurgitationMR
ARNI_ inhibitorsangiotensin-receptor neprilysin_ inhibitors
myocardial_ loss IRS1 iRS2 heart_ failure p38alpha MAPK insulin resistance
Heart_ failure preserved ejection_fractionHFpEF cardiovascular_ morbidity mortality
process_redesign contextual framework
peak aerobic_ capacity left-hand_ grip_ strength waist_ circumference anxiety
clinical_ variables ecCT
control group exercise
circulating_forms NT-proBNP
PVf PB_ cycle low BP
eCG_ parameters cRT
sST2 low-dose_ BB cardiovascular_event_rate
HF_hospitalization
exercise peak_vo2joint_effect
spironolactone guideline-recommended
transfusions heart_ disease
breast_cancers trastuzumb-related_ CHF clinical_ trials
Kansas_city Cardiom_ Questionnaire heart_ failure preserved ejection_fraction
tissue doppler_ imaging left ventricular_ filling_ pressure systolic_heart_ failure
heart failure_mice hypertensive_heart_مرض angiotensin II infusion nephrectomy salt loading
pde2 failing_hearts acute β-AR_stimulation
remote_monitoring_RM
pharmacologic_ treatment clinical_ trials pharmacologic targets
chronic_against_sector
low eGFR diuretics uncontrolled_ hypertension ESRD
RV dysfunction cardiac_ cachexia
time-dependent_analyses IE risk heart_ failure HF cRT-D
heart_ failure hospitalisation elderly
mechanical_dissynchrony narrow QRS_ complex cRT
clinicians anemic iron-deficient adult_patients
carotid intima-media thick
psoriasis patients atherosclerosis cardiovascular events psoriasis
coronary occlusion collateral_ growth stent occlusion
aggressive_ dose uptitration HR_reduction beta-blocker
trastuzumab
Point-of-care_systems ED community_outpatient_settings acute_heart_ failure
o-CFUs reduced_ mortalityhazard_ratio
isoprenaline_infusion SDQT HF
HF_ remodeling EMd dyssynchronous_ failing_heart
surgery HF hypertension vasodilators diuretics
acute_heart_ failure
clinical_ trials aldosterone_ antagonist heart_ failure
angiogenesis post-myocardial_infarction_heart progression heart_ failure
arterial_ compliance TAC end-systolic_ elastance ees
heart_ failure preserved ejection_fraction myocardial_infarction community
Renal_disfunction all-cause mortality cardiovascular_ events primary isolated_caBG
biventricular_support HeartMate_II_LVAD CentriMag_rVAD
anthracycline congestive_heart_ failure haematopoietic_cell transplantation
coronary_ artery_ disease systolic_heart_ failure unclear etiology
cardiovascular_factor diabetes mellitus atrial_fibrillation coronary_ artery HFpEF
Renal_disfunction myocardial_infarction coronary_ artery_ bypass_ graftingCABG
Shunt transseptal_ catheterisation transoesophageal_echocardiographic general anaesthesia
single-arm
HDL_function CHF ET HDL-mediated_vascular
HF_risk_factor unfit_ men
implementation strategies physician adherence HF_PGs
baseline Ea TAC HR ivabradine placebo-treated
ERC pure_epicatechin

Care management content-driven telehealth technology high-cost Medicare beneficiaries
dopamine nesiritide pooled placebo
Clinicians nonprescribing chart_review
biomedical reasons nonprescribing
black_race HF_hospitalization cardiovascular_ mortality
eGFR VAD_group ECMO_group
MEDline EMBASE cochrane clinical_registries technical advisors
HF
Pyridostigmine vascular_ endothelial_ growth_factor_ protein left_ ventricle myocardial_ angiogenesis
baseline_cRF HF_ mortality_risk

Robot-assisted_ gait_therapy Lokomat_system heart_ failure
elastic_n2Bus_ segment PEVK
cardiac_ growth_plastity disease recapitulates developmental chromatin_ remodeling
myocardium displays post-translational pKA downstream_signaling
cXL-1020 HNO inactive CXL-1051
quantitative_ proteomics chromatin-associated_ proteins detergent
CHF classification_of_ Diseases Ninth_revision codes
idiopathic dilated_ cardiomyopathy_cohort
atrial_fibrillation carvedilol metoprolol
RV_ dysfunction lower_ body_ mass index cachexia
HeartMate_II insertion biventricular_support HeartMate_II implantation
pharmacologic acute_HF adverse_ event_rate chronic_HF
tNF_ antagonists HF_hospital admissions nbDMARDs RA
Nicorandil mitochondrial_ dysfunction doxorubicin-induced_heart_ failure cardioprotection
functional MS valve plasty degenerative_ MR LV
ST-segment-elevation_ MIs Killip conditions
HeartMate left_ ventricular_assist_system lVAS
grounded_theory heart_ failure_ patients implantable cardioverter-defibrillator
baseline NT-proBNP MR-proANP MR-proADM
arterial_ elastance pulsatile_ afterload pressure
epidemiology myocardial_infarction
admission brain natriuretic_peptide bNP creatinine natremia
management_of end_state_heart_ failure public_health_problem
RAS hypertension nephropathy congestive_heart_ failure
isoelectric_ focusing RIα ser77 ser83 vivo phosphorylation
Self-Care_of_heart_failure_index
SDQT RR_ intervals QTV heart_ratio
Heart_reduction exercise_performance heart_ failure reduced ejection_fraction beta-blocker hypo-response
heart_ failure mechanical_support devices Cardiology-Cardiovascular_Surgery_conensus_report Heart_ failure progressive_مرض
HF HF_drug_ treatment PAF biosynthetic_ enzymes lyso-PAF-AT
physician adherence
voluntary_ testimonies
exercise
risk-adjusted_ mortality
patients ejection
incidence HF complicating AMI high_ mortality
Physician_ volume HF low-volume_institutions noncardiologist_ physicians
sST2/low-dose BB sST2/high-dose_ BB
gls
CHF_visits
LV ejection_fraction PCWP
cardiac_events
Validation_system zebrafish Nucleolin genomic reprogramming_ events disease
eGFR VAD_group ECMO+VAD renal_function
cardiac_ magnetic_ resonance_ imaging t1_mapping invasive_hemodynamic
mADIt-CRT multicenter Automatic_ Defibrillator_ Implantation Cardiac_resynchronization_therapy
aUCs e/eseptal e/emean s'septal QRS resynchronization
diuretics HF-related morbidity
public_health air pollution industrial_ areas hospitalisation
hospital heart_ failure follow-up
devices gastrointestinal_ bleeding
carvedilol metoprolol heart_ failure devices
IVC occlusion twist apical_rotation RS synchrony CS
Logistic_regression_models secondary_ outcome_of_ death confounders
heart_ failure_HF risk_ stratification_ models inpatient outpatient_models
Morbidity HFpEF
congestive_heart_ failure
BET bromodomain-containing_ proteinBRd4 cardiac_ tissues
molecular_biomarkers pathophysiology chronic HF
emergency_ department acute_heart_ failure_ clinical_ trials enrollment
intravenous_ iron exercise_tolerance heart_ failure
Medicare inpatient_data HF admissions acute_hospitals
eCG congenital_accessory_pathways ion_ channelopathies cardiomyopathy
mouse HF_model HHD salt loading uninephrectomy ANG II infusion
mitral_plasty degenerative_ mitral_regurgitation
erythropoiesis-stimulating_agents anemia heart
idiopathic_ dilated_ cardiomyopathy Tuscany evidence-based management
in-trial_ resource_ utilization unit costs Québec_health_board disease-specific_ costs Ontario_case Costing_initiative
HF preserved ejection_fraction pEF uptitration hospitalization
heart_ failure t2d type 2 diabetes Skm skeletal_ muscle
RAS neprilysin_ inhibition chronic_heart_ failure systolic_ dysfunction
t1-mapping_sequence tidal_ respiration gadolinium-chelate_agent
HF_ rats pyridostigmine basal_heart rate vagal sympathetic_control_of_heart rate
DAPc dtrophin-associated_ protein_ complex sarcomeric_microstructure baseline
cardiopulmonary_velocity peak_ quadriceps
low-dose dopamine low-dose nesiritide acute_heart_ failure renal_ dysfunction acute_heart_ failure randomized trial
catheter ablation atrial_fibrillation heart_ failure preserved ejection_fraction
Myocardial titin hypophosphorylation heart_ failure preserved ejection_fraction rat metabolic_risk
AF ablation
ejection_fraction
economic_model
combining_ parameters multiparametric echocardiographic_ score
initiative follow-up
trends HF
HeartMate_II_LVAD temporary CentriMag_RVAD
HFpEF kccq health_status
Chronic_heart_ failure transforming growth_factor beta-dependent_ yield atrial explant-derived c-Kit_cells
Mortality inpatient admissions hospital_ days emergency_ department
RV_ failure management_procedures intrinsic left_ ventricular_ dysfunction
baseline serum_ratinine serum_potassium
PD_ initiation diuretic_ response peripheral_ edema functional
anemia chronic_heart_ failureHF
If-channel_ inhibition hemodynamic_status exercise tolerance heart_ failure preserved ejection_fraction
Cardiac insulin-resistance mitochondrial_energy systolic_heart_ failure pressure-overload hypertrophy
echocardiographic_predors response cardiac_resynchronization_therapy cRT
circulating NT-proBNP antibodies nonglycosylated nonterminal epitopes
exercise_programme
onset HFrEF exercise_ performance resting HR beta-blocker_therapy
end-stage_heart_ failure pediatric mechanical_ cardiac
nbDMARD tNF_ antagonist baseline_covariates
Hum-Retn_mice cardiac mRNA_level inflammatory cell adhesion_ genes Retn_mice
baseline PAF metabolic_ enzymes heart_ failure
chromatin_ subproteomes heart_ failure chromatin_ structure
heart_ failure nurses cardiology
pyridostigmine administration methylatropine propranolol cardiac sympathovagal_ balance
preoperative renal_ dysfunction early risk_of_ stroke myocardial_infarction heart_ failure
myosin binding_ protein-C phosphorylation Ser23/24 troponin_I phosphorylation HF
trastuzumab adjuvant_setting cardiotoxicity congestive_heart_ failureCHF
Phosphodiesterase-2 human failing_hearts blunts beta-adrenergic cardiomyocytes
cox_ hazard_models ESRD

deactivation
costs high-volume_ physicians
nutritional_abnormalities CHF fat carbohydrates proteins water
doxorubicin serum resistin Hum-Retn_mice
pigs inferior vena_cavaIVC
direct_observation rheumatic MS
university_of_connecticut heart_failure_center cardiologist heart_ failure nurse_practitioner
XO_ inhibition cardiomyocyte_ bioenergy LV chronic ACF rat
heart_ failure_HF maximal cardiopulmonary_test anaerobic_ threshold
uPR_effectors protein kinase R-like ER_ kinase perk calreticulin CHOp HF
carvedilol thromboembolic_ events heart_ failure β2-receptor haplotype
HF_ rats pyridostigmine ejection_fraction cardiac_ output contractility left_ ventricle
echocardiographic_ measures N-terminal pro-brain natriuretic_peptide inflammatory_ markers
randomised-controlled_ trialsRCTs observational_cohort
aldosterone_ receptor_ antagonists morbidity_ mortality symptomatic systolic_heart_ failure
economic_ climate NHS behavioural-change_interventions chronic_مرض exercise_facility acute_hospital
dialysis-dependent HF cRT_ implantation
VAD_group ECmo_group
women_health_initiative HF_hospitalization
post-HCT_ CHF
RV_disfunction
Peak_ consumption oxygen_ pulse
CV_ deaths non-fatal_ stroke hospitalisations heart_ failure
middle-aged_ recreational_ athletes sudden_ cardiac_ deaths atherosclerotic CAD
biomarkers molecular_ dysfunction chronic HF
Ambient air pollution cardiovascular_health acute_myocardial_infarction
rhythm_control_therapy AF cardiovascular_ complications AF
sCN5a transcript uPR downregulation cardiac_ genes HF
medical_hospitalization HF
prospective_ validation_cohort
albumin_ levels inflammation hepatic_function
tp_theory downward regression_ line_ shift nonsurvivors higher PASP
mAIN_oUTCOME_measures gLS index beat_ method CV_event cox proportional_ hazards
hearts Mena cardiac_ injury HF pathophysiology
Olmsted_ County MI HF
CHF-developed infarcted_animal left ventricle_ end-diastolic_ pressure scar
non-ischemic ischemic_heart_ failure biomarkers
lipolysis energy expenditure a- natriuretic_peptidesNPs CC
neurohumoral_blockers HF_hospitalization low co-morbidity_ burden
Kccq Kaplan-Meier_ curves
right ventricular RV left ventricular_assist_ device lVAD
temporal incidence odds_ratio_hazard_ ratio HF AMI discharge
Testosterone_therapy exercise_ rehabilitation chronic_heart_ failure low testosterone_status
cox proportional_ hazards demographics health_status
AMI heart failure kidney infection UTI
reclassification_of risk c statistic net reclassification_of_risk integrated discrimination
RAS doppler_ ultrasonography computed tomographic_angiography magnetic_ resonance_angiography
cRT-D IE_risk defibrillator-only_therapy
diagnostic_procedure
lVAD transplantation eligibility_status program budget
hypoalbuminemia postoperative_ mortality left ventricular_assist_ device lVAD
left_ ventricular_ejection_fraction long-term_ mortality heart_failure_ Survey
renal_underperfusion renin- angiotensin-aldosterone_pathway
atrial_fibrillation atrial_tachyarrhythmias ATP shock_therapy
percutaneous coronary_revascularization hemodynamically
nicorandil cardioprotection apoptotic_ signaling_pathway DNA_ fragmentation mitochondrial ultrastructural
obesity diabetes mellitus metabolic_risk_factors heart_ failure preserved ejection_fraction
proteomics pressure-overload-induced_heart_ failure mitochondrial-targeted peptides
inhibition vascular_ endothelial_ growth_factorVEGF compensatory_ hypertrophy cardiac_ failure
IC multicenter_automatic_deibrillator_ Implantation_Trial-Cardiac_resynchronization_therapy
speckle tracking echocardiography STE biVP acute right_windricular_ pressure_overloadRVPO
Cardiopulmonary echocardiographic myocardial_function left ventricular_ filling
health_ Buddy_program chronic_obstructive_ pulmonary_مرض mortality congestive_heart_ failure
HR dynamics time-domain HR variability risk_ stratification
occurrence HF index AMI
LVEF
uPR na+ channel mRNA_ splice_variants reduction cardiac na+ current human HF
diuretic_efficacy adverse neurohormonal_activation congestion-like fluid_overload
apoptosis pathogenesis_of_heart_ failure
BETs transcriptional_ pause_release transcription pathological stress
ANS_mice LV fractional_shortening lung_weight
ecbNP HF
dose uptitration HR_reduction
eCG atherosclerotic_ CAD sudden cardiac_ death
incident systolic_heart_ failure spironolactone hospitalization
perk_ inhibition full-length sCN5a Kv4.3 mRNA_level na+ channel mRNA splice
dysfunction naturally occurring Rad_variant_Q66P congestive_heart_ failure
functional_ enrichment_analyse programmed_cell_ death common DEGs
Mena expression HF
controlled_ randomized_ trials
intestinal_morphology absorption_function CHF
NP_ measurement NPs clinical_care emergency
Trastuzumab CHF nontrastuzumab
atrial_fibrillation_AF heart_ failure HF progress anticoagulation
Fontan_ failure circulatory_derangement hemodynamic portal_ hypertension augment cardiac_ output
echocardiographic_ score LV reverse_ remodeling
LVEF long-term_ mortality acute_decompensated_HF
bottleneck_ stent timing myocardial_infarction antiplatelet medication
salt loading uninephrectomy ANG II infusion_ mouse_model cardiac_function HF
biventricular_support HeartMate_II lVAD CentriMag right_ ventricular_assist_ deviceRVAD
Blood_ pressure arm cuff stroke_ volume ejection_fraction end-diastolic_ volume echocardiography
fibrosis_of_heart_ failure_myocardial_ tissue left_ ventricular_ tissue trichrome blue histologic
Kansas City_city_cardiom_ Questionnaire HFpEF
atrial_fibrillation atrial_fibrillation Stroke
tricuspid annular_ plane systolic_excursion pulmonary_ arterial_ systolic_pression heart_ failure right ventricular_contractile
high-volume_ physicians
divergent etiology comorbidities
exercise_training therapy
cardiac_ hypertrophy
myocardial_DD high muscle_ strip stiffness titin hypophosphorylation
right_ ventricular_RV body_ composition
ARNI cardiovascular_ mortality hospitalization heart_ failure
functional MS valve plasty annular_size_reduction degenerative_ MR LV dilated
EO-CFUs lower CD34_vegFR2_cells functional_capacity nondiabetic_ patients
HF-ACTION_cohort baseline_ Hgb baseline_HRQoL KCCQ
Frailty heart_ failure biological_ phenotype accumulation_of_ deficits
functional MS valve plasty degenerative_ MR LV
idiopathic dilated_ cardiomyopathy
pathological_ remodelling heart cardiac hypertrophy HF fibrosis inflammation
peak_work_rate peak_ quadriceps_force
exercise anaerobic_ metabolismpeak_ respiratory
virtual_cohorts resource_ use costs
patients borderline
RAS- β-blocker uptitrations HFrEF HFpEF hospital admission
American College_of_ Cardiology_American_ Heart_Association guidelines RAS
NT-probNP_level plasma dyspnea left ventricular_ dysfunction admission ED
implantable cardioverter-defibrillator_deactivation
Circulating_progenitor_cells cPCs endothelial_ repair cardiovascular_مرضs
contractile_function LV_dilatation end-diastolic_press_wall_ stress lung
LV remodeling diastolic_ properties XO_ inhibition hospitalizations
Caucasian sNP_ rs10927887 Ka renal_ chloride_ channel_ geneCLCNKA
ventricular_assist_ device VAD extracorporeal_ membrane_ oxygenation ecMO renal_function
cardiac magnetic_ resonance amyloidotic_ pattern multiple_ myeloma osteomedullary_ biopsy
HFpEF echo-Doppler_cardiography invasive haemodynamic
Implantable cardioverter-defibrillatorsICds cardiac resynchronization_therapyCRT
Vascular_ endothelial_ growth_factor_blockade beta-blocker_therapy cardiac_function angiogenesis remodeling heart_ failure
low-sodium DASH_ diet diastolic_function ventricular-arterial_ coupling hypertensive_heart_ failure preserved ejection_fraction
bt DT cost-effectiveness_limits
expenditure health per capita gross_national income_per capita HF
blood_control goal-directed lipid-lowering_therapy smoking_ cessation RAS
bNP inhospital_ mortality
SDQT HFVT HFVT HNorm_ group fixed-rate_atrial_pacing
is cRT-D_ recipients
AF
frail biological_ phenotype
HFPEF longitudinal_ outcome-monitoring_ phase cardiac
Physician_ volume HF
t1-mapping diffuse_ myocardial_ changes heart_ failure contrast_agent breath-holding
eplerenone HF-REF inducing hyperkalemia WRF
exercise-induced PASP
RM strategies discharged
LBBB implantable_ cardioverter_defibrillator-CRT
QRs morphology cardiac_resynchronization_therapy cRT
aberrant reactivation embryonic_ gene programs pathological_heart_مرض transcription factors
standard_error_of_ measurement mDC
sST2/low-dose BB sST2/high-dose_ BB cardiovascular_ events
centrifugal_ flow_pump hemocompatibility magnetically levitated_rotor blood-flow_paths artificial_ pulse
biomedical_ treatment dCM heart_ failure
multiparametric echocardiographic_ score reverse_ remodeling cRT clinical_ outcomes
emergency_ department acute_heart_ failure aHF clinical_ studies
Yorkshire swine pacemakers ventricularly_ paced
isolated_heart_rate_HR ivabradine afterload systolic_heart_ failure
mitochondrial_ complex_V activity post-AAC phosphocreatine ATP
skeletal_ muscle_ sarcomere_ structure heart_ failure type 2 diabetes epicatechin-rich cocoa
ST2 cardioprotective_signaling myocardium biomarker heart_ failure
MI_animal metoprolol plasma norepinephrine dopamine epinephrine
Cardiovascular_outcomes Renal_ Atherosclerotic_Lesions CORAL stenting RAS
mortality heart_ failure implantable_ cardioverter_defibrillatorsICDs
Mediterranean_dietary_approaches Stop_ HypertensionDASH diet_ scores mortality postmenopausal_النساءHF
NP_level

electronic_ databases MEDLINE EMBASE PsycINFO
patient-level regression risk-adjusted_ mortality readmissions costs
LBBB QRs implantable cardioverter_defibrillator-CRT
echocardiography reduced cardiac_ diameters b-treated vehicle-treated rats
quality_of_life functional_capacity
therapeutic left-to-right interatrial_ shunting heart_ failure ejection_fraction
heart_ failure severe hypertension mitral_regurgitation mitral_ stenosis
antagonists renin-angiotensin-aldosterone sympathetic_system CHF
exercise-induced_ PASP pulmonary_ hypertension ventricular_contractile_ reserve
cardiovascular_ death heart_ failure myocardial_infarction
implantable cardioverter-defibrillator Heart_ Function_ Clinic university_health_networkToronto
perk_activation sCN5a Kv4.3 channel mRNA transient_ receptor cation channel m7TRPM7 channel mRNA
Cardiac-resynchronization_therapy cRT morbidity_ mortality chronic_ systolic_heart_ failure QRS
systolic_HF left_right_heart_ filling_ pressures systemic_vascular_ resistance cardiac stroke
HF_risk_factor HF_ epidemiology SH_cd rheumatic_ fever
caloric_ restriction aerobic_ exercise_exercise QOL
mice cardiac_myocyte-sensitiv Mena_ overexpression tgtetMena cardiac_pathology
outpatient_ assessments patients heart_ failure hospital discharge readmissions
baseline_hgb baseline_kccq_ scales exercise_training HRQoL
HFpEF diastolic_ filling_ time controlling heart_ rate
chronic_heart_ failure_HF purely hemodynamic_ disorder syndrome dysfunction interconnected molecular_pathways
international right_heart_ Foundation_working_group
guideline-recommended medications heart_ failure reduced ejection_fraction outpatient
truncated na+ channels unfolded_ protein_ response uPR sCN5a electric_ remodeling HF
cardiac_ hypertrophy pressure-overload abdominal_aortic_constriction
risk_ stratification antiplatelet_agent anticoagulants vascular_مرضs
allopurinol LV contractile_function XO-mediated ROS myofilament_ca(2+)
crude ankle-brachial_index pulse-wave_velocity coronary_ artery calcium
myofiber dynamics myofiber shortening prolonged EMd dyssynchronous HF
Fontan_ failure hemodynamically traditional heart_ failure low systemic_ vascular_ resistance sVR_index preserved_ cardiac_index
follow up body_weight FM fFM
physical_activity HF_ mortality
data processing differential_ analysis packages R Cluster
rehospitalization Medicare_hospital_ claims Medicare post-acute_care_policy
isolated_heart_ transplant
median rate_ratio
therapeutic_strategy AF severe_heart_ failure financial
physicians advanced_heart_ failure
risk_of_heart_ failure refill compliance etidronate alendronate
metabolic exercise cardiac kidney index score
et HDL-mediated_protecive_effects molecular_pathways chronic_heart_ failure
β-adrenergic_ receptor_blocker_therapy myocardial_perfusion neoangiogenesis failing_heart
interagency_ Registry mechanically_assisted_ Circulatory_support
Meta-analysis left ventricular_ejection_fraction left ventricular_diastolic_ end_ diameter
left ventricular_ejection_fraction heart_ failure preserved_ejection_fractionHFpEF
prevalence eccentric concentric_centric_ left_thrombophlebitis_ hypertrophy_heart_ failure preserved ejection_fraction
sCN5a angII hypoxia exogenous_variants uPR downregulation na+
HF hyperkalemia hypokalemia spironolactone
systolic_function HFpEF long axis_function exercise
receptors g-protein-coupled_ receptor_ kinase-2 desensitization downregulation
NT-probNP_assay nonterminal_ epitopes central glycosylated_region
low-dose dopamine nesiritide decongestion renal_function
logistic regression
HART HFpEF HF_ejection_fractionHFrEF
concurrent_HF odds_ratio 28-day_ mortality hazard_ratio
Extracellular_ matrix left_ ventricular_ biopsies TissueFAXS technology
left ventricular_assist_ devices lVADs patients advanced_heart_ failure pump_ replacement
defects perturbed bone morphogenetic_ protein_4 expression rRNA transcription heterochromatic_ chromatin
elevated resistin anthracycline-induced_ cardiotoxicity heart_ failure macrophages
actin_ cytoskeleton mitochondrial_function intermediate_ metabolism glycolysis_gluconeogenesis citrate
tachypacing-induced HF contractility end-systolic elastance venoarterial dilation
ST2 clinical_ variables amino-terminal_pro-B-type natriuretic_peptide
diagnostic_ approaches clinical_ trials
alendronate etidronate raloxifene-treated
implantable_ cardioverter_defibrillator-CRT non-LBBB QRS duration
kccq_ domains HFpEF cronbach
metric
saxagliptin sitagliptin follow-up_data pairwise
anemia iron_deficiency MEDline cochrane_ Library
Sprague-Dawley rats sham aCF allopurinol
sST2 low-dose_ BB cardiovascular_event
myocardial_ collagen traditional myocardial delayed_ enhancement_ imaging
biomedical_ treatment dCM heart_ failure
serum levels creatinine bNP furosemide_ dose oxygen flow dobutamine norepinephrine
biventricular_pacing biVP cardiac_co
contemporary_heart_ failure HF therapies HF preserved left_ ventricular_ejection_fractionLVEF
systolic_HF Danish_heart_failure ESRD Danish_ Registry_on_Dialysis
trastuzumab_ use comorbidities CHF international_ Classification_of_ Diseases healthcare Common_procedure_coding_system codes
transplantation
cRT_group hazard_ ratio
neurohormones adipokines body_ composition progressive_ratio fat_free massFM
expression mistargeting regulation Rad_Q66p RGK_ protein
cardiac_plasma_ membrane s1PR1 counterbalance β1AR_ overstimulation heart_ failure
AlphaLISa immunoassays antibodies extreme N c termini circulating NT-probNP
fully magnetically levitated_velocity_risk Seattle_ Heart_ Failure_model-predicted_ survival
Myocyte_ hypertrophy_ antecedent_to heart_ failure global_ gene expression DNA_accessibility
Catheter ablation_for AF compensated HFPEF left_ ventricular_LV_ ejection_fraction
New York_heart_association_NYHA chronic_heart_ failure reduced_ejection_fraction Canadian
Swedish_national_inpatient_ Registry rehospitalization stroke myocardial_infarction heart_ failure
Hospitalized_ Heart_ Failure Saxagliptin Sitagliptin antihyperglycemic_drugs
cox proportional_ hazards_models score death transplantation LV_assist_ device_ implantation heart_مستشفى
Nicorandil phosphocreatine adenine nucleotides mitochondrial_ oxidative_phosphorylation_capacity creatine kinase
intraclass correlation_coefficientICc kappa_coefficient standard error_of_ measurement mDC
exercise_training chronic_heart_failure controlled_Trial_ Investigating_outcomes exercise_traiNingHF-ACTION
cardiomyocytes mechanical humoral_stimuli myocardium workload
biventricular_support
BB therapy exerted_ dose-related_benefits sST2_mechanism chronic_heart_ failure
CHF cardiac_ explant c-Kit_progenitors elucidate mechanisms regulation
ESRD systolic_HF eGFR
transitions_of_care_program self-management_training out-patient_ follow-up
functional_efficacy pure HNO_ donor myocardial_function HF
TUnel_assay apoptotic_cells TUNEL-positive_cells paced
length-force_ relationship RV_function
biological_ phenotype medical_ records ascertain_frailty
tachycardia intravenous atropine cardiac_ vagal_ tone CHF-DNx CHF-INV
transitions_of_care program congestive_heart_ failure non-urbanized Midwestern state South Dakota
s HH medical_support office_ hours
surgically induced myocardial_infarction heart_ failure_ rats bisoprolol vehicle
SDQT HFVT HNorm_ group acute β-adrenoceptor_ blockade esmolol
study_design
Peritoneal_ dialysis diuretic_ resistant_ volume_ overload heart_ failure
hano_ donor isolated_myoctyes intact_hearts HF
Peripheral_ artery_PAD heart_ failure HF
heart_ failure preserved_ejection_fraction HFPEF heart_ failure overweight
Renal_ dysfunction heart_ failure_HF dysfunction end-stage renal_مرضESRD
Nicorandil aortic_ blood flow mitochondrial_ oxidative_ stress doxorubicin cardiotoxicity
peripheral_ muscle_pump cardiac_ filling subpulmonary_ ventricle Fontan_ circulation
echocardiographic_ score LV reverse_ remodeling LV end-systolic volume
Cardiology_practices national_cardiovascular_dia Registry_practice_innovation Clinical_excellence
heart_ failure left_ ventricular_ ejection spironolactone
physical_ examination bmi weight heart rate rhythm lying standing_ blood_ pressure pulmonary_congestion
myocardial_extracellular_ matrix cardiac_ magnetic_ resonance_ T1_mapping pathobiologypathophysiology prognosis
undirectional left-to-right interatrial_ shunting patients heart_ failure reduced ejection_fraction
aldosterone_ antagonist_therapy chronic_ advanced_heart_ failure post-myocardial_infarction_heart_ failure
preoperative renal_ dysfunction cardiovascular_ eventsstroke myocardial_infarction heart_ failure isolated coronary_ artery_ bypass grafting
clinical heart_ failure CHARM_programmeCandesartan Heart_ Failure_ Assessment Mortality Morbidity
single-procedure drug-free
protocol-driven POC_test NP patient_ consultation ED
physician_ volume mortality internists cardiologists
shuttle walk_test body mass hand_ grip_ strength baseline
capillary coronary_perfusion ad-Flk rats b-treated ad-C rats
exercise cell senescence
leaflet serial evaluation subvalvular annular_ MS fixed_ ring_size
strength_of_ race contemporary chronic_heart_ failure_HF exercise
asymptomatic pediatric Fontan_PF catheterization
dyssynchronous_ nonfailing HF canine_ electromechanics
anemia HF health-related_quality_of_lifeHRQoL
hfff caloric_ restriction aerobic_training peak_vo2
cell_therapy chronic_heart_ failure explant-derived_progenitor_cells
Lancet air pollution heart_ failure high morbidity mortality
abnormal_HR_ variability AMI diagnosis CHF/LV_ dysfunction
Troponin_t N-terminal pro-B-type natriuretic_peptide biomarker heart_ failure_risk atherosclerosis_risk
ventricular_assist devices cardiac_ nurses gastrointestinal_ bleeding
extended_crime cardiac_ transplant ecCT transplant_pool
prospective HF_ registry HF
mortality_hospitalization cardiovascular_ mortalityHF_hospitalization
American_col_of_ Physicians anemia iron_deficiency heart_مرض
BAT N-terminal_pro-brain natriuretic_peptide HF
MI-induced septum_systolic_ thickness LV posterior_wall_ thickness LV internal_ diameter metoprolol
tachycardic methylatropine vagal_ tone bradycardic propranolol sympathetic_ tone
cox regression spironolactone_ use hospitalization severe hyperkalemia acute kidney_ injury
acute_RV_ failure chronic pulmonary_ arterial_ hypertensionPAH acute pulmonary_embolism
mitochondrial oxidative_phosphorylation_capacity creatine kinase oxidative stress_ markers DNA_ fragmentation ultrastructural
cardiac resynchronization_therapy cRT mild_heart_ failure QRS ejection_fraction
Fraction_ flow_ reserve measurements positron_ emission_ tomography_ imaging severe ischemia bottleneck stenting left_ ventricle proximal LAD
economic_analysis Patient_management_ Interventions Heart_ Failure cost-Effectiveness_model
Neprilysin_ inhibitors natriuretic_peptide breakdown atrial natriuretic_peptide b-type natriuretic_peptide
Functional_elektral_stimulation peripheral_ muscles endothelial_function heart_ failure_ patients preserved left_ ventricular_ejection
baseline SDQT-to-SDRR_ratio HFVT HFVT hNorm
altered ventricular_structure fiber_sheet orientation handling slowed conduction wall stiffness
Rad Q66p cardiomyopathy l-type channel-dependent_processes
serum resistin anthracycline-containing_Chemotherapy cardiotoxicity
sst2 titrated high-dose_ BB cardiovascular_event_ rate lowest cumulative_ hazard
postoperative hypoalbuminemia normal_albumin_ concentration
renin-angiotensin_system_ blocker beta-blocker therapy heart_ failure preserved left ventricular_ejection
exercise medical_therapies Cardiac_ Function exertional Shortness_of_ Breath_ Due Lung_congestion
nurse assessment cognitive_ impairment hospitalization physician discharge cohort elderly patients heart_ failure
heart_team cardiologists cardiovascular_ surgeons medical
HF-ACTION HF HF ejection fraction
bisphosphonates alendronate etidronate risk_of_heart_fail
acute RV_ failure pulmonary_embolism
TAPse PASP nonsurvivors HFrEF HFpEF
Chinese_medicine adjunctive_ treatment dilated_ cardiomyopathyDCM heart_ failure
Baroreflex_sensitivity time domain heart_ rate_ variabilityHRV CHF-INV sham-INV renal DNx
hypertension diabetes mellitus systolic_ murmurs
cardioprotective_effect nicorandil hemodynamic mitochondrial_ dysfunction doxorubicin rats
bundle_ branch_ block electrical_activation dyssynchronous_heart_ failure electromechanical_ behavior
in vivo inhibition miR-25 antagomir spontaneous cardiac_ dysfunction murine myocardium heart_ failure Hand2-dependent
NT-probNP admission all-cause_ mortality acute HF
epigenetic_writer_ proteinshistone acetyltransferases epigenetic_erasershistone deacetylases cardiac
haematopoietic_cell_ transplantation haematopoietic_cell_ transplantation hCT_ survivors congestive_heart_ failureCHF pre-HCT anthracyclines
carvedilol nonselective β-blocker β-blocker_metoprolol thromboembolic_ events heart_ failure
quality HF AMI pna
baseline_crime cardiac_ transplant_ survival
dietary_ recommendations patients heart_ failure HF
arrhythmia_ substrate AMI HR_ variability
treated hypertension compensated HFPEF DASh/SRDtarget sodium
deranged_ca(2+) handling EMd dyssynchronous HF remodeling
ejection_fraction cardiac_index inotropes inotrope
doxorubicin-induced_ cardiotoxicity Hum-Retn_mice littermate human resistin
diastolic_disfunction pathophysiology HFpEF non-diastolic_ abnormalities cardiovascular
8-fluo-cAMP binding wild type phosphomimic Ser77 ser83 mutant RIα double_mutant WT_riα
high-density lipoproteinHDL endothelial-protective endothelial_cell nitric oxideNO
Dialysis HF hospitalization
outcomes admission to discharge hospitalized_hospitalized_hospitalized_hospitalized_hospitalized_hospitalized_persons heart_ failure_HF Nursing_outcomes ClassificationNOC
hHF saxagliptin sitagliptin antihyperglycemic_agent
preoperative albumin mortality LVAD_ implantation
systolic_heart_ failure QRS_ duration cRT rate_of_hospitalization heart_ failure
differentially_ expressed_ genes non-ischemic ischemic_heart_ failure healthy_control
reoperation driveline_ infection gastrointestinal bleeding debilitating_ stroke
cox regression_ models propensity_ score decile oral glucocorticoid_ dosage HF_hospitalisations loop_diuretics
insulin_ resistance type 2 diabetes insulin_ receptor_ substrates iRS2 insulin-signaling_elements regulating cellular metabolism
dyssynchronous HF electromechanical_delayEMD local myocyte depolarization myofiber shortening_ onset
Beta_blockers readmissions heart_ failure ejection_fractionHFrEF heart_rate
Functional_elektral_stimulation fes exercise_capacity emotional stress endothelial_function chronic_heart_ failure systolic_function
right_atrial_myxoma pulmonary_ arteries right_atrial_ mass removal pulmonary_embolectomy
transplant ineligible patients HF volume management clinical_data pre-PD initiation
statistical_standards biomarker-guided clinical_ trials multimarker-based
SAF_cohort abnormal liver_ textures nodularity
Frailty biological_ phenotype weak grip_strength physical_ exhaustion low activity unintentional_weight
cRT-D IE IC
low-volume_ EDs discharge patients heart_ failure home
QRs morphology cardiac resynchronization_therapy resynchronization-Defibrillation Ambulatory_ Heart_ Failure_TrialRAFT
acute right_heart_ failure therapy refractory_ cardiogenic_ shock heart_team corporeal_ membrane_ oxygenation cPRICU
office-based emergency_room_practices undiagnosed_heart_ заболевания HF
Bax bcl-2 mRNA_ expression moderate_heart_ failure bcl-2/Bax
heart magnetic_ resonance_ imaging chelation_ choices single-institution_cohort heart_ failure arrhythmias
nitroxyl_hNO Angelis salt exerts positive inotropic lusitropic vasodilator_effect cAMP
ejection_fraction_EF pre-PD
cPCs early-outgrowth colony-forming_ unitsEO-CFUs circulating CD34 vEGFR2 CD133_cells
clinical_effectiveness continuous-flow_LVADs heartMate II HeartWare bTT DT
anticoagulation rate control cardiovascular_ complications acute_heart_ failure atrial_fibrillationAF
baseline EF
bp inhospital_ mortality
DASh_diet_ scores HF Mediterranean_Diet scores
skeletal_massa relative appendicular_ lean_ mass_index age-matched sex-matched
ST2 functional_capacity well-treated cohort ambulatory patients HF reclassification_of_risk
quality_of_life all-cause mortality
cultured_ cardiomyocytes JQ1 drug abrogated phenylephrine-induced_ genes
CLCNKA polymorphism heart_ failure glomerular_ filtration_rate RENASTUR
cardiovascular_疾患s heart_ failure HF
cardiac_veGF Akt endothelial_no synthase_activation drug-untreated failing_hearts
psychosocial_factors exercise_adherence Heart_ Failure_ Patients HF-ACTION
heart_ failure left ventricular_ systolic_ dysfunction
derivation_cohort coronary_ angiography systolic_HF unclear etiology
cardiac insulin-resistance insulin-stimulated_ rates glycolysis glucose oxidation plasma membrane translocation glucose transporter
angiotensin II angII hypoxia activators abnormal SCN5A mRNA splicing overexpress SCN5A
exercise-induced_ PASP right ventricular_contractile_ reserve
arterial_ elastance end-systolic_ elastance ventricular-arterial_ coupling ratio Ees
baseline post-DASh_srd_srd_brachial central_ blood_ pressure radial_ arterial_ tonometry echocardiographic
Gene expression_profil gse9128 Gene Expression Omnibus non-ischemic_heart_ failure ischemic
rhythm_control_therapy antiarrhythmic_ drugs catheter ablation electrocardiographic_ device
expenditures noncardiovascular_ diagnoses implantable cardiac_arrhythmia devices noncardiovascular_ drugs rate-control
HF reduced_ejection_fractionHFrEF
Extracorporeal_life_support bridging_therapy acute ischemic right_heart_ failure refractory_ cardiogenic_ shock reperfusion therapy
heart_ failure left ventricular_ejection_fraction exercise_capacity emotional_status endothelial_function HFpEF
intubation_ rates
hearts TTA tgtetMena_mice wild-type littermates transgenic_mice
raloxifene mechanism_of action
onset_ HFrEF exercise_ protocol respiratory_gas
guideline-recommended drugs heart_ failure biomedical_ reasons
black_race chronic_HF exercise_performance HF
wasting_of_weight lean_ mass adverse outcome fat_ loss enhanced catabolism adipose_ tissue cardioprotective
lVADs CF_ devices Thoratec_ Corp Pleasanton_ Calif hVAD_ devices HeartWare intl Framingham Mass
hearts_of_fish lacking_nucleolin abnormal chamber_ patterning cardiac_looping myocyte
HF immunoreactive NT-probNP c-terminally truncated_ fragments NT-probNP_ molecule
plasma NPs total_ adiponectin FM fFM NPs adiponectin
Macrophages cardiomyocytes Hum-Retn_mice doxorubicin hRetn_human_ resistin mRNA protein expression
beat-to-beat QT_ interval surface_eCGsatrial pacing esmolol isoprenaline atropine infusion
withdrawal_of_ sympathetic_ tone parasympathetic_ tone heart rate_ response intravenous bolus_of_metoprolol atropine
EH_denotes HFpEF HFrEF HFrEF_therapy
adverse_ event_ rates acute myocardial_infarction congestive_heart_ failure in-hospital adverse_ events
limits_of agreement
follow-up_ visits
cardiac_ tissue TAC- sham-operated JQ1 vehicle BET_ inhibition pathological_ cardiac_ gene expression
power_spectral_analyse low-frequency low-frequency high-frequency LF/HF_ratio CHF-inv sham-inv sham_ levels DNx
non-terminal pro-B-type natriuretic_peptideNT-proBNP misdiagnosis heart_ failure
HF-ACTION left_ ventricular_ejection fraction New York_ Heart_association IV HF exercise_training
myocardial_DD collagen_deposition titin_ modification obese diabetic ZSF1 rats heart_ failure preserved ejection_fraction
cardiac_ magnetic_ resonance postcontrast_ T1_ time HFPEF postcontrast_ T1 biomarker HFPEF
contractility ventricular-arterial_ coupling ivabradine-treated
conditional_ gene-targeted Hand2_mice pressure-overload-induced hypertrophy fibrosis ventricular_disfunction fetal_ gene_program
admission NT-probNP prescriptive_4-year_ survival ED acute HF
clinical_ prediction_ rule CAD angiography systolic_HF cost
epigenetic_ readers cardiac_ biology cardiac_ gene control chromatin-dependent_signal transduction abrogate pathological HF
Systolic_ blood_ pressure left_ ventricular_LV_ hypertrophy AN ANS
follow-up heart_ failure sudden_ death noncardiac cardiac_ transplant
percutaneous_revascularization angioplasty stenting
load-corrected_ chronotropic_ response exercise baseline follow-up_tests
Peak_production_VO2max resting_ HR
cox-proportional_ hazard_ models negative binomial_ regression models intervention survival_ utilization demographic health
HF t2d ERC treadmill_testVO2max oxygen_ consumption SkM biopsies
gastrointestinal_ bleeding incessant ventricular_tachycardia storm terminal_procedure
Chronic β-AR_stimulation catecholamine infusions rats enhanced PDE2 expression cAMP hydrolytic_activity blunted_ cardiac β-AR responsiveness
HF QRS prolongation LVEF reverse_ remodeling
chronic_pAH hospitalized acute RV_decompensation pharmacologic therapies RV_ failure_management PAH
patients non-survivors
comanagement clinicians nonadherence clinicians medication
non-frail_ participants severe_frailty Gill_index HF
health ABC_short_phyal_ Performance_battery Gill_index incident_HF
RV_support lVAD_insertion cardiogenic_ shock myocardial_infarction chronic_decompensated_heart_ failure
Chronic_heart_ failure_CHF multisystem_ disease anemia insulin_ resistance autonomic_disbalance cardiac cachexia
Xanthine oxidase XO rat left_ ventricular_LV myocytes volume_ overload mitral regurgitation aortocaval_fistula
obese zSF1_group heart_ failure preserved_ejection_fraction lung_weight preserved left_ ventricular_ejection_fraction left_ ventricular DD
high-volume physicians low-volume_hospitals
western_au linked administrative_ health_data
consensus_report
nursing-sensitive_ outcomes
between HF AMI
miRNAs noncoding RNAs regulate expression target genes sequence-specific untranslated messenger RNA translational_repression
free-breathing_ pulse_sequency myocardial_ T1 swine_model tachycardia-induced_heart_ failure
HFpEF ivabradine placebo
PF_cohort New York_ Heart_association
ecs diagnosis heart_ failure
Cardiac c-Kit_cells cardiac explant-derived_cells cardiac_functions myocardial_infarction
pathophysiology HF medical_management
inhibitor BETs chromatin downstream signalling RNA_polymerase pol II
NPs pulmonary_embolism diabetes
empirically_deved composite_quality_ measure heart_ failure acute_myocardial_infarction pneumonia
intestinal_ barrier chronic_ inflammatory_state catabolic_anabolic_ imbalance cardiac cachexia terminal_ stage CHF
epidemic heart_ failure preserved_ejection_fractionHFpEF
diminished cyclic adenosine_ monophosphate cAMP augmented cyclic guanosine_ monophosphate cGMP failing_hearts
mortality healthcare utilization_effects care management telehealth congestive_heart_ failure chronic obstructive_ pulmonary_مرض diabetes mellitus
catheter ablation atrial_fibrillation_AF heart_ failure preserved_ejection_fraction
report ischemic-hypertensive_ cardiomiopathy angina inducible myocardial_ischemia coronary arteries
RA methotrexate tNF_ antagonist non-biological_مرض_modifying_antirheumatic_drugnbDMARD
cox proportional_ hazards regression_modeling risk_factors acute_ coronary_ syndromes coronary_interventions
sphingosine-1-phosphate receptor s1PR1 β1-adrenergic_ receptorβ1AR g-protein-coupled_ receptors heart
e_septal PCWP e/e'lateral e/e'mean
inappropriate_therapy atrial_fibrillation carvedilol metoprolol
gLS LVEF sa predicting adverse CV_ events conventional clinical echocardiographic_ systolic_ parameters AF
Bradycardia intravenous_metoprolol cardiac_ sympathetic_ tone CHF-INV rabbits sham-INV CHF-DNx
cPG-recommended pharmacological_ treatment device
randomized_controlled_ trial Nordic_ walking standard_ cardiac_rehabilittion_care functional_capacity
Rad_Q66p limits inhibitory_action Rad_oncav1.2 cav1.3 l-type_ channel isoforms heart
EF LCX_model LAD_model stenting left_ ventricle LCX LAD
signalling cascades microRNAs bHLh_ transcription_factor Hand2 postnatal mammalian_ myocardium embryonic_ genes heart
ERC induced_ recovery DAPC_ protein levels sarcomeric_microstructure markers SkM growth myofibre_ regeneration
mv surgical_ ring implantation leaflet_ motion edge-to-edge anastomosis
HART New York_heart_association NYHA HF HF
BET bromodomain_ proteins bets acetyl-lysine_ reader_ proteins HF
cardiac_functionvia echocardiography diastolic_ dysfunction E/E systolic_ dysfunction ejection_fraction
aldosterone_ antagonism heart_ failure aldosterone electrolytes
LV end-diastolic_ volume LV_ end-diastolic_ pressure hg β_coefficient
Grading_of_recommendations_evaluationGRADe
HF_hospitalization
uniform_ nomenclature right_heart_ circulatory_ failure conjoint_éducation mechanisms
influx L-type voltage-gated_ca(2+) channels plateau_ phase ventricular_action_ potentials excitation-contraction_EC coupling myocardium
AT1 receptors neprilysin blocks renin-angiotensin-aldosteron RAS axis natural vasodilatory diuretic natriuretic_peptides
ivabradine exercise_capacity left ventricular_ filling heart_ failure preserved_ejection_fraction
blood transfusions iron erythropoiesis-stimulating_agent anemia congestive_heart_ failure coronary_heart_مرض transfusion
high bNP glomerular_ filtration_ rate hypertension transmitral E-wave_early_diastolic_ mitral_velocity
β-blockade cAMP-dependent_ protein kinase downstream β-adrenergic_ receptor post-translational
erythropoiesis-stimulating_agent_therapy venous_thrombolism
clinical CHF_predive_model curve genetic
black_race mortality_hospitalizationhazard_ ratio cardiovascular_ mortalityHF_hospitalization
percutaneous one-vessel_model chronic myocardial_ischemia stent polytetrafluoroethylene bottleneck
centers Medicare and Medicaid_services cms operationalized hospital quality_of_care outcomes publicly risk-standardized_ mortality readmission penalties
heart_ failure tumor_ necrosis_factorTNF_α tNF_ antagonists HF
signal transduction cascade transcription_factor pathological cardiomyocytes transcription_factor epigenetic chromatin_structure
cox proportional_ hazard_ models time-dependent covariates follow-up familiar_ physician discharge urgent_all-cause_ readmission
logistic analysis peak_ oxygen_ uptake metabolic_ exercise cardiac kidney_index score
annular_ size reduction surgery diastolic_ mitral_ valve tethering anterior leaflet opening posteriorly displaced_ papillary_ muscle left ventricular_ dilatation
hypertensive HFPEF sodium-restricted DASH_Diet ventricular_diastolic_function arterial_ elastance ventricular-arterial coupling
CHF after_hCT polymorphisms anthracycline metabolism iron homeostasis anti-oxidant_defence myocardial_ remodelling
logistic regression rule severe_CAD diameter_ stenosis 3-vessel_ CAD proximal left_order_ artery
incidence_ mortality heart_ failure acute_ myocardial_infarction western_Australia
Randomized_aldactone_ Evaluation_ Study symptomatic chronic_ advanced_heart_ failure_ patients aldosterone_ antagonist spironolactone
medication
pathophysiological_ origin
lVAD_ surgery hypoalbuminemia
scientific_ literature HM II economic_evaluations
creatininehazard_ ratio post-transplant_ mortality
complications lVAD_therapy transplantation eligibility_status device bTT medical therapy
radial_ artery_ tonometry_ variables admission
randomized_ trials HR variability_turbulence risk_ stratification cardiac
low-dose dopamine low-dose nesiritide renal_function
risk_of_ death glomerular_ filtration_ rate
Medicare_ coverage stage I-III breast_cancer chemotherapy sEER-Medicare Texas_cancer_ Registry_Medicare
signalosome scaffold_ protein kinases sequential phosphorylation effector
fully magnetically levitated centrifugal-flow chronic_LVAS
diseased_ cardiomyocytes pde2 activity cGMP nitric oxide_ donors pde2 inhibition β-AR
ejection_fraction b-type natriuretic_peptide_ levels heart_ failure inhospital outcomes guideline-Heart_ Failure_ Registry
beta1-adrenergic receptor sphingosine-1-phosphate receptor s1PR_ reciprocal_ downregulation cardiac_ hypertrophic_ response heart_ failure s1PR1 cardiac_ gene therapy
ECs HDL phosphorylation eNOS-Ser eNOS-Thr PKc-βII-Ser p70s6k-Ser
sts HM
mouse ventricular_myocytes sarcomere peak_ca(2+) transient
administrative_ databases province_of_ Alberta discharged alive hospital first-time diagnosis
low pasp peak o2 per kilogram
cRT_on_ assignment time to death HF_hospitalizationhazard_ratio LVEF
heart_ failure myocardial_ collagen tissue
L-DKO_mice cardiac IRS1 IRS2_ proteins heart_ failure impaired cardiac_energy_ metabolism p38α mitogen-activated_ protein kinase
nicorandil doxorubicin-induced_heart_ failure hemodynamic_ perturbations mitochondrial_ dysfunction ultrastructural antitumor_activity
Rhythm_control_therapy diagnosis AF atrial_ structure sinus rhythm delayed rhythm_control
relative_risk_RR_of_heart_ failure bisphophonates crude_RR
physician adherence guideline_ recommendations heart_ failure
acute_heart_ failure renal_ dysfunction low-dose_ dopamine low-dose nesiritide decongestion renal_function diuretic therapy
HF skinfold_ thickness dual-energy_ X-ray_absorptiometry echocardiography blood
high-cost Medicare fee-for-service_ beneficiaries Centers Medicare Medicaid_services propensity-score
hospitals heart_ failure_HF acute myocardial_infarction pneumonia
Patients enrollment_ periods heart_ failure_ treatment
kccq_ summary_ scores New York_heart_association HFpEF HF
aCP restrictive red_cell_transfusion_stratestrigger_ hemoglobin_ threshold higher_ hemoglobin_ levels coronary_مرض
implanted left-to-right interatrial_ shunt haemodynamic heart_ failure reduced ejection_fraction
Caloric_restriction aerobic_training Peak oxygen_ Consumption Quality_of_life Obese Older Patients Heart_ Failure Preserved_ejection_Fraction
left_ ventricular_assist devices lVADs chronic end-stage_heart_ failurebridge to transplantation bTT transplant-ineligible patients
right ventricular-pulmonary_ arterial_ couplingpulmonary_vascular_ resistance right_ ventricular_ejection_fraction
carvedilol metoprolol implantable cardioverter-defibrillator_therapy MADIT-CRT_ trial
oral_ glucocorticoids dose-related gradient HF_risk
HR ivabradine_ group ea TAC
HFPSI risk_of_ death medical_hospitalization HF clinic outpatients HF resources
systemic_ adverse_ events ethnic_group
carvedilol inappropriate_therapy metoprololhazard_ratio
testosterone_ supplementation exercise_ rehabilitation CHF low testosterone_status
peak_vo2 percent lean_ body_ mass thigh_ мышц_intermuscular_ratio
guidelines-heart_failure HF borderline EF
cox_models PASP exercise peak o2 per kilogram
cardiac insulin-restance decreased mitochondrial oxidative metabolism metabolic cardiac hypertrophy energy
rGK rem Rem2 Rad Gem/Kir monomeric_G_ proteins ventricular_action potential_ duration EC_ coupling cardiac_type_activity
annular_ size reduction surgery diastolic_ mitral_ valve tethering anterior leaflet opening posteriorly displaced_ papillary_ muscle left_ventricular_LV dilatation
pathophysiology heart_ failure preserved_ejection_fraction HFPEF myocardial_extracellular_ matrix
breathing_control cardiac arrest pulseless_ ventricular_fibrillationPVF cardioverter-defibrillator_ device
N-terminal proBNPNT-proBNP midregional proANPMR-proANP adiponectin bMI FM
acetylcholine_ inhibitor_ pyridostigmine sympathovagal_ balance cardiac_function HF myocardial_infarction
cardiac_ sympathetic activity i-meta-iodobenzylguanidine i-MIBG β-blocker
Swedish_web-system enhancement evidence-based_care Heart_مرض Recommended_therapies_ registry
LVEF clinical composite_ response reverse remodeling_ parameters HF_hospitalizationhazard_ratio
brain natriuretic_peptide bNP
pde2 cgmp cAMP_hydrolysis negative cross_talk cGMP cAMP_signaling
tAPselongitudinal RV_ fiber_shortening PASPforce_generation in vivo RV length-force disclosing
mitochondrial-targeted antioxidant protective_peptides Szeto-Schiller SS20 proteomic_ remodeling signaling_pathways
economic_analysis Patient_management_ Interventions Heart_failure cost-Effectiveness_model
re-hospitalization admissions
coprimary_ end points cumulative_ urine_ volume decongestion_ end point serum cystatin_C
cardiac_ arrest cardiopulmonary_ resuscitation cPR posterior_wall_infarction cardiac_centre
diabetes saxagliptin pioglitazone sulfonylureas long-acting insulin
hyperkalemia mineralocorticoid_ receptor_ antagonists heart_fail
erythropoiesis-stimulating_agents congestive_heart_مرض
ambulatory patients heart_ failure_HF reduced ejection_fractionrEF renin-angiotensin_system RAS β-blockers
uPR scn5a human ventricular_ systolic HF_ tissue human induced pluripotent_ stem_cell-derived_ cardiomyocyteshiPSc-CMs
coPD CHF cRF ICC kappa_coefficients
implantable cardioverter-defibrillator_deactivation implant clinical_status end-of-life
stable_heart_ failure left ventricular_ejection fraction aerobic_training lower_ limbs
heart_ failure poor myocardial_function dilated contracting_ ventricles aetiologies
cochrane_effect_practice organisation_of_care_taxonomy
mouse_Rad_Q65p murine human_ Rad Q66p l-type_ currents caV1.3_chans wild-type_Rad
implantable cardioverter-defibrillator_deactivation_ preferences distressing implantable_ cardioverter-defibrillator_ shocks
mouse_heart_ failure_HF model hypertensive_heart_مرضhHD pathophysiology therapeutic_ targets HHD
MI_ characteristics yielded_ hazard_ ratios
national Medicare patients acute_hospital HF AMI pNA
ctnt NT-probNP aRIC_HF_model
baseline sST2_status baseline sst2_status high ng/mL
incubation EC HDLNYHA-IIIb phosphorylation eNOS-Ser eNOS-Thr HDL
patients hospitalized HF LVEF long-term_ mortality
sarcoplasmic_ reticularSR_ca(2+)-uptake SR_ca(2+)-pump phospholamban infarcted_hearts metoprolol
global left_windricular_ longitudinal_ systolic_ strain gLS left_ ventricular_ mechanics adverse_ cardiovascular_CV atrial_fibrillationAF
early-onset HF HF HF preserved_ EF
carvedilol von Willebrand_factor metoprolol β2-adrenergic_ receptor haplotype
exercise intramuscular_ testosterone_ supplementation chronic_heart_ failure_CHF low_ testosterone
heart_ failure_HF plasmab-type natriuretic_peptide bNP ejection_fraction sex
gLS outperformed left_windricular_ejection_fractionLVEF systolic_ mitral_ annulus_velocity sa
home telemonitoring implanted_monitoring_ devices medical_support office hours structured telephone_supports human-to-human contact human-to-machine interface HM
test-retest_retest_retest_retest Timed up_go tg_test patients advanced chronic_ obstructive_ pulmonary_ရောဂါ_coPD chronic_heart_ failure_CHF chronic_ renal_ failure
cox regression beta-blockers beta-blockers inappropriate_therapy antitachycardia_pacing aTP shock_therapy
pediatrics religious_ beliefs life-sustaining_ treatment
patient_ preferences priorities guideline-recommended_ medications
cost rhythm-control rate-control
median_âge женщин median left_ ventricular_ejection fraction median eGFR
CD34_veg_2_cells functional_capacity CD34_veg_2_cells peak_vo2
fit unfit cRF_ distribution hazard_ratio unfit_men overweight obese_men
Medicare_ Patient_ Safety_monitoring_system_MPSMS adverse_ event_rate patients hospitalized acute myocardial_infarction congestive_heart_ failure pneumonia surgery
HFPSI model blood urea nitrogen b-type natriuretic_peptide New York_ Heart_association diabetes_status atrial_fibrillation_flutter
cRT_group control_group hazard_ratio
crude 28-day case-fatality_ rate concurrent HF case-fatality_ rate
practice-level guideline-recommended_ treatment outpatients heart_ failure reduced ejection_fraction practice
sampling_frames CHF race/ethnicity cumulative anthracycline_ exposure stem_cell autologous
resting_ tension_of_sarcomere_leng relations kcl-KI treatment titin extracellular_ matrix Fpassive
aerobic resistance_training exercise_capacity muscle_strength cardiac_protbNP inflammatory hsCRP
differential_impact hospital_ performance readmission_ metrics all-cause_ readmission aCR potential_ Preventable_ Readmission pPR Centers Medicare Medicaid 30-day_ readmission cMS
reversibility_of_heart_ failure myocardial_infarction β-adrenoceptor_blockade infarcted_ rats metoprolol
exercise_duration
congestive_heart_ failure_ visits
Excessive_ secretion arginine_ vasopressin aVP physiologic_processes CHF inhibition aVP vasopressin_ receptor_ antagonist_therapy CHF
physical_therapy implantable defibrillators circulatory_ support transplantation risk_ stratification heart_ failure therapies disease
rats hearts caspase-3 activity phosphocreatine adenine_ nucleotides cytochrome bcl2 Bax caspase 3 expression
rapid right_ ventricular_pacing Bax bcl-2 Caspase-3 RTq-PCr interventricular_ septum_ biopsies beagle_dogs
angiotensin-converting_ enzyme inhibitors_angiotensin_ receptor_blockers β-blockers
sodium-restricted_ dietary stop hypertension_DietDASH/SRD left ventricular_diastolic arterial_ elastance ventricular-arterial_ coupling hypertensive HFPEF
acute_HF_ trials RELAX-aHF ASTRONAUT PRONTO
metoprolol carvedilol sympathetic_activity von_Willebrand_factor Arg16/Gln27 gly16/Glu27
Hospitalized_HF International_ Classification_of_ Diseases Ninth_revision Clinical_ Modification codes
Rad Q65p gating_ movement wild-type_ Rad Q65p_substituion rGK_ proteins
heart_ failure global_proteomics actin_ cytoskeleton_pathways mitochondrial metabolic_pathways
echocardiograms left ventricular base midpapillary apex baseline IVC occlusion biVP twist basal rotations RS
pyridostigmine coronary_ artery_ ligation cardiac vagal sympathetic_ tone cardiac_ remodeling HF
joint_of_outcomes New York_heart_association class II_of_heart_failure eplerenone placebo standard_heart_failure_ Medicines
discharge
life_ expectancy treatment_of_heart_ failure
heart_discharges university_of_connecticut_health_center
Pulmonary_ capillary_wedge_ pressure right_atrial_ pressure pulmonary_ resistance
acute_heart_ failure_HF pharmacologic_studies calcium-sensitizing agents endothelin vasopressin adenosine
aortic_insufficiency mechanical_ circulatory_ support continuous flow left_ventricular_assist devices pulsatile_ devices
HF induced mice phenylephrine haemodynamic_ stress surgical transverse aortic_constriction jQ1 cardiac_ hypertrophy
direct renin_ inhibitors neutral endopeptidase_ inhibitors vasopeptidase_ inhibitors angiotensin_ receptor_blockers
pde2 overexpression healthy cardiomyocytes cAMP_level L-type_ca2 current_ amplitude inotropic acute β-AR_stimulation basal_contractility
bottleneck_ stent proximal left_ anterior_ descending LAD proximal circumflex_ artery proximal LCX mid LAD
acute_meocardial_infarction acute_meocardial_infarction AMI
i-MIBG cardiac_ washout carvedilol metoprolol_ treatment β2-adrenergic_ receptor haplotype
Muscle aerobic_capacity postexercise postexercise phosphocreatine resynthesis Fontan
Cardiac_resynchronization_therapy cRT dialysis_dependent heart_ failure
eplerenone hyperkalemia renal_function EMPHASIS-HF
H-DKO_mice reduced ventricular_ mass cardiac_ apoptosis fibrosis
reduction inappropriate_ ATP inappropriate_ shock_therapy
cardiorespiratory_fit cardiorespiratory_fit body mass index heart_ failure unfit_ men
postmarketing_ trials risk hospitalized_hHF dipeptidyl_ peptidase-4 dPP-4 antihyperglycemic_agent
quality_ improvement_ database multivariable cox_modeling Heart_failure_ Patient_ Severity_index HF_ clinic
Heart_ratio cardiac patients acute myocardial_infarction AMI congestive_heart_ failure left_ ventricular_LV
neonatal_ rat_ ventricular_ cardiomyocytes chronic insulin_ exposure IRS2 proteins insulin_action p38
echocardiograms left ventricular_ midpapillary_level atrioventricular_delay interventricular_delay VVd regional circumferential_ strain radial_ strain
New York_heart_association HF ejection_fractions chronic_ guideline-directed_ medical_therapy
non-LBBB QRS hazard_ratio
pKA_ subunits type II regulatory rIIα catalytic cα phosphorylation HF
abnormal_ca(2+) handling dyssynchronous HF myofiber shortening_velocity early-activated septum myofiber shortening stretch_ratio late-activated lateral_wall
CHF-derived c-Kit_cells transforming growth_factor-β tGF-β epithelial mesenchymal_ transition_ markers pluripotency_ markers shams
label-free_shotgun_proteomics global_proteomics transverse aortic_constriction TAC signaling_pathway
hFrEF left_ ventricular_ejection fraction HFpEF left_ ventricular_ejection fraction RAS- β-blocker index HF
p70s6k PKC-βII HDLNYHA-IIIb malondialdehyde bound_HDL
g-protein-coupled_ receptors reciprocal_ regulation chronic β-adrenergic_ receptor_stimulation postischemic_heart_ failure
weight exercise_group exercise_group
NT-proBNP inflammatory_biomarkers hsCRp IL6
sex ejection_fraction frail biological_ phenotype risk_of_ death
resting_HR baseline VO2max
TGF-β inhibition c-Kit_cell_ phenotype function in vitro cardiac_progenitor_function cell expansion
BETs neurohormonally_ induced_heart_ disease nanomolar_ doses JQ1 phenylephrine-mediated_ hypertrophy cardiomyocytes pathological_ gene induction
concentric_ remodeling_CR concentric_ hypertrophy_CH left_ ventricular_LV heart_ failure preserved_ejection fraction eccentric_ hypertrophyEH
BAT exercise_capacity N-terminal pro-brain natriuretic_peptide burden_of_heart_ failure GDMT-treated_ NYHA
MLHF MLHF_ total_ score exercise
nonpace non-DNx sham-Innervated sham-inv nonpace DNx sham-DNx pace_inv
exercise_ time PSSS
hemoglobin hgb HRQoL training-induced HRQoL cohort_of patients Heart_ Failure HF-ACTION
risk_of_ event RV_ dysfunction haard_ratio
atrial_fibrillation congestive_ Heart_ Failure_ trial health care expenditures rhythm rate-control treatment
calcineurin_nfat_signalling miR-25 expression basic helix-loop-helix transcription_factor dHAND diseased human mouse_myocardium
heart_ failure myocardial_ ischaemia tachy- bradyarrhythmias valvular_regurgitation pulmonary_embolism renal_ dysfunction
HABC_battery_ score HF_risk health ABC HF_model SD_risk competing_risk
NT-probNP cutoff_point admission pg/mL
prognostic_power rapid R-R interval_oscillations non-linear HR_ variability short-term fractal_ scaling_exponent
heart_she patients spontaneous_ ventricular_tachycardia HFVT
gLS cox_model chronic_heart_ failure hypertension diabetes prior_ stroke_ score glomerular_ filtration_ rate LVEF adverse CV
diastolic_ filling_ formalism relaxation viscoelastic passive_stiffness doppler_ mitral_inflow_velocity e-wave
VAD ventricular_assist_ device_support ECmo_group extracorporeal_ membrane oxygenation_ membrane_support ECmo VAD
functional status NYHA HFpEF HFrEF HFpEF HF_hospitalization
cost-effectiveness heart_ failure_management_programs evidence-based_therapies health_system
humanized mouse murine_ resistin human Retn_ gene hum-Retn_mice basal inflammation-stimulated_ resistin
angiotensin-converting_ enzyme inhibitors_angiotensin_ receptors_blockers β-blockers
TTA tgtetMena_mice cardiac_ injury ejection_fraction fractional_ shortening heart_dilatation transverse aortic_constrictionTAC
heart_ failure_patients confirmatory_factor_analyse cfa SCHfi self-Care_management Self-Care_ Confidence
resynchronization-Defibrillation Ambulatory_ Heart_ Failure_Trial implantable cardioverter_defibrillator_defibrillator-CRT
ischemic_eventos ischemic_ cardiomyopathy cardiac_ resynchronization_therapy defibrillator cRT-D device
renal_ dysfunction chronic_ obstructive pulmonary diabetes peripheral_vascular_dia diabetic left_ ventricular_ejection_fraction ICD_ shocks ischemic_ cardiomyopathy male sex
CHF CHF
Raf-MEK1/2-ERk1/2 scaffold_ proteins adaptive maladaptive_ cardiac_ remodelling
functional_ MS LV dilatation heart_ failure HF LV prolapse degenerative_ mitral_valve
angiotensin_ converting_ enzyme_ inhibitor angiotensin_receptor_blockers β-blockers heart_ failure
New York_heart_association kccq overall_ Summary Total_distributions Spearman_ correlations HFpEF interaction_ terms
LV ejection_fraction LV_ strain_ratio systole diastolic_ indices LV_ strain_ratio diastole early_transral_ flow sinus rhythm
c57b figure ANG II infusion uninephrectomy ang II infusion salt loading uninephrectomy salt_loading
early transmitral_ blood_ flow_velocity doppler early_diastolic_mitral_ annulus_velocity pulmonary_ capillary_wedge_ pressure decompensated_ systolic_heart_ failureHF
peak_vo2 exercise
AMI hospital
kccq HFpEF
ctnT NT-probNP laboratory_report
Mass spectrometry N- c-terminally_processed_forms circulating NT-proBNP physiological_ proteolysis pro2-Leu3 leu3-Gly4 pro6-Gly7 pro75-Arg76
HFpEF patients New York_ Heart_association class_II
depressed left_ ventricular_LV_ systolic_ pressure pressure ejection fraction_ shortening cardiac_ output
baroreflex_activation_therapy Heart_failure Reduced_ejection_Fraction
enrollment
HF risk_factors raised_ blood glucose_ levels obesity tobacco systemic_ hypertension_SH rheumatic_ fever Chagas_مرض
age- sex-adjusted_risk early-onset_HF
adjusted hazard_ratios low_CRF_categories obese body_index categories
baseline eGFR eGFR group uncontrolled_ hypertension diuretics
myocardial_phosphodiesterase-2 pde2 heart failure HF pde2-mediated beta-adrenergic_ receptorβ-AR diseased_ cardiomyocytes
cardiac_resynchronization_therapy defibrillator implantable cardioverter-defibrillator_ device carvedilol inappropriate ATP_therapy metoprolol
epicatechin-rich cocoa Skm mitochondrial_ structure
follow-up_ visits risk_of_ death urgent_ readmission
Mena overexpression TTA/tgttttttttt_Mena_mice TAC
institution diuretic_refractory severe-end-stage HF
ATP_production mitochondrial_ oxidation glucose lactate fatty_ acids myocardial_ glycolysis
proangiogenic_effects B activation veGF_pathway adenoviral_ vector decoy_veGF_ receptor control_adenoviral_virus ad-C
eplerenone potassium potassium hyperkalemia
bottleneck_ stent proximal LAD LCX reversible_ myocardial_ischemia open_ stent ischemic_heart_ failure
New York_heart_association_class III_of_heart_fail HF left_windricular_ejection pb
potassium spironolactone non-AAs
symptom_limit maximal_CPET CHF control exercise
echocardiography reduction LV end-diastolic volume disappearance MR mitral_ valve_ opening mean pressure_ gradient
post-LVAD aortic_valve oversewing leaflet repair bioprosthetic aortic_valve_ replacement CF_LVAD
veterans va health_care systems systolic_heart_ failure β-blocker angiotensin_ converting_ enzyme_ inhibitor angiotensin-receptor_blocker
exercise-induced pulmonary_ artery_ systolic_ pressure stress_doppler_echocardiography right_ventricular_contractile_ reserve pulmonary_ hypertension right_heart_ failure
literature_search MEDLINE EMBASE HEalthSTAR cINAHL cochrane_ Library Campbell_collaboration Joanna Briggs Institute evidence_based_practice_centres
heart_ failure blockade neuro-hormonal_system angiotensin_ converting_ enzyme_ inhibitorsangiotensin_ receptor_ blockers angiotensin_ converting_ enzyme_ inhibitors_intolerance mineralocorticoid_ receptor antagonists
open_ chest twist twist RS RS synchrony STE regional_ strain biVP
TAPse-to-PASp_ratio cox regression Kaplan-meier
obese_ participants body mass index chronic_ stable_hFPEF
human_heart_ failure mRNA splicing voltage-gated_ cardiac_na+ channel α-subunit encoding truncated endoplasmic_ reticulum
paediatric_heart_ failure myocarditis dilated_ cardiomyopathy new onset_ heart_ failure anthracycline childhood_cancer_therapies
economic_analysis Patient_management_ Interventions Heart_ Failure cost-Effectiveness_model
natriuretic_peptides b-type NP N-terminal pro-B-type NP acute_dispnea
peak_velo2 ven/vco2 slope exercise oscillatory_ ventilation eOV partial_pressed_co2PETco2 cardiopulmonary_test
national_ retrospective_cohort_ study bisphosphonates raloxifene general_ population
longitudinal_ strain left_ ventricle echocardiographic_ measurements baseline echocardiography follow-up echocardiograms
severe hypertension LV dilatation LV dysfunction mild MR mitral_ valve restricted_closure organic_lesion systolic diastolic_ tethering
HDL_controls CHF-NYHA-IIIHDL_NYHA-II
platelet-activating_factor_PAF metabolic_ enzymes
acute_care surgery oHT transplantation medical_therapy intravenous inotropes ventricular_assist devicesVADs
renin-angiotensin-aldosterone_system renin-angiotensin-aldosterone_system RAAS angiotensin_converting_ enzyme inhibitors angiotensin_ receptor_blockers aldosterone_blockade HFpEF
HFpEF ivabradine exercise_capacity left ventricular filling_ pressure exercise peak early_diastolic_mitral_velocity
admission lVET unfavorable outcome
heart rate blood pressure renal_function spironolactone RAS_blockers β-blockers
cardiac_ performance β-adrenoceptor_blockade heart_ failure SR_ca(2+)-pump reverse cardiac_ remodeling plasma catecholamines
congestive_heart_ failure_ phenotypes mitochondrial TAC
HF-ACTION exercise_ training HF low_windricular_ejection_fractions HRQoL Kansas_city Cardiomyopathy_ Questionnaire kccq
tolvaptan congestive_heart_ failure diuretic_therapy serum sodium_level systolic
depressed myofibrillar_ca(2+)-stimulated_ ATP_activity mRNA_level SR_ca(2+)-pump phospholamban α-myosin_ heavy_ chain metoprolol
coronary_microembolization-induced HF left ventricular_ end-diastolic_ pressure myocardial_ oxygen ejection_fraction ventricular_power_index
baseline heart_ failure t1-mapping_ values administration contrast_agent
standard_error_of_ measurement_ value MDC 95% confidence_level
HF idiopathic dilated_ cardiomyopathy c'd ischemic SH valvular alcohol
ST2_level functional_capacity ambulatory patients HF Heart_ Failure controlled_Trial_ Investigating_outcomes exercise_training HF-ACTION
carvedilol metoprolol inappropriate implantable cardioverter-defibrillator_therapy MADIT-CRT multicenter_automatic_deibrillator_ Implantation Cardiac_resynchronization_therapy
angiotensin-converting_ enzyme inhibitorsangiotensin_ receptor_blockers_therapy β-blockers
ischemic HF_pathogenesis NYHA_function_class IV glomerular_ filtration_rate heart_rate diabetes_ mellitus myocardial_infarction
cRT resynchronization reVErses resynchronization_reverses Systolic left_ v_Entricular_disfunction reVERSe left_ ventricular_ejection_fractionLVEF
signaling_ paradigms activation β1ARs s1PR1s myocyte cAMP receptors regulatory_activity g-protein-coupled_ receptor_ kinase-2
PAF-CPT lyso-PAF-AT lp-PLA2
elateral s'lateral aUC
rate-control cardiac_procedures cardioversions cost antiarrhythmic_ drugs
spironolactone risk_of_hospitalization
descriptive_ assessment diabetes_ mellitus cardiomyopathy β-blocker angiotensin-converting_ enzyme_ inhibitor angiotensin_II receptor_blocker
eplerenone post_myocardial_infarction_heart_ failure survival_studies post-myocardial_infarction_hospitalizations aldosterone_ antagonist eplerenone
cardiopulmonary_ exercise_testing_guide exercise_ rehabilitation patients chronic_heart_ failure
risk_reduction heart_related_ mortality sudden_ death
DASh/sRD 24-hour brachial_ systolic_ pressure central_ end-systolic_ pressure
all-cause mortality hospitalization HF LVEF
HF obese body_index ≥35 kg/m2 black_ ethnicity idiopathic-dilated_ cardiomyopathy
idiopathic_ dilated_ cardiomyopathy negative_ angiography
european_society_of_cardiology guidelines HFPEF heart_ failure preserved LV_ ejection non-dilated left_ ventricle diastolic_disfunction
glomerular_ filtration_ rate eGFR type 2 diabetes total_cholesterol CLCNKA GG genotype
echocardiography LV end-diastolic_dimension LV end-diastolic_ pressurewall_ stress lung_weight untreated ACF
heart_ failuremean ejection fraction standard_ cardiac_ rehabilitation_care Nordic_ walking
dRS-stratified_ hazard_ ratios pioglitazone sitagliptin sulfonylureas insulin
skeletal_ muscle_massa t-score
RAS- β-blocker_ uptitrations composite_ end-point_of_all-cause_ mortality HF_ readmissions HFrEFhazard_ratio
testosterone baseline peak_ oxygen_ uptake Beck_depression_inventory leg_strength
patients enrolled Heart_failure controlled_Trial_ Investigating_outcomes_of_ Exercise_ TrainingHF-ACTION
ST2 cardiovascular_ death HF_hospitalizationhazard_ratio log2_ratio
New_heart_association cardiopulmonary_ exercise lean_ mass_ quantification dual x-ray_absorptiometry calf_ muscle magnetic_ resonance_spectroscopy
placebo low-dose dopamine low-dose nesiritide diuretic_therapy renal_function
randomized_ trials cRT New York_ Heart_association class III IV_heart_ failure left_ ventricular_ejection QRS_ duration echocardiographic_dissynchrony
left_ ventricular_LV ejection fraction HF right-sided cardiac_ catheterization transthoracic_ echocardiography transmitral_ flow_velocity mitral_ annulus_velocity diastole
acute coronary syndromes
HF lyso-PAF-AT PAF-CPT PAF-AH lp-PLA2
medical therapy redo sternotomy aortic_valve_procedures bioprosthetic_valve_ replacement dacron patch_closure aortic_ valve_ repairs transcatheter aortic_valve_procedure open_chirurgian aortic_ valve_ replacement
plasma N-terminal_pro-B-type natriuretic_peptideNT-proBNP
cardiac troponin t t tnT high-sensitivity_assay N-terminal pro-B-type natriuretic_peptideNT-probNP incident_HF HF_risk_in_communities Atherosclerosis_risk_in_communities
body_index lower event_ratioHR_per kg/m
participants median age 70y median body_ mass index
reverse_ remodeling ejection_fractions HF_hospitalizations dialysis
covariates reduced LV_ contractility lower_velocity_velocity_ratio systolic_ blood_ pressure end-systolic_ volume
echocardiography end-diastolic_ volume_ index LV ejection fraction mild_ MR mitral_valve_ opening MVA pressure_ gradient
double-blind placebo-controlled clinical_ trial renal_optimization_strategis_evaluation roe patients acute_heart_ failure renal_ dysfunction glomerular_ filtration rate
BETs chromatin-mediated signal transduction pol II co-activating transcription_factor_networks HF_pathogenesis nuclear_factor_of_activated_ T_cells nuclear_factor-κbNF-κb transcription_factor GATA4
mortality exercise tolerance cardiovascular_ events myocardial_infarction congestive_heart_ failure arrhythmia cardiac_event
EO-CFU diabetes EO-CFU peak_vo2
all-cause cardiovascular_ mortality
immunoblotting radioenzymatic- fluorescence_ resonance_energy_transfer-based_assays video edge_ detection epifluorescence_microscopy l-type_ca2
exercise_capaci peak_ oxygen_ consumption mL/kg/min co-primary_ outcome
east atrial_fibrillation_for_ Stroke_ prevention_Trial
low_wind_ejection_fraction patients HF preserved left_ ventricular_ejection_fraction hospital acute_outpatient_settings financial
TAC-induced_ proteomic_ alterations mitochondrial-targeted_peptide_ SS31 perturbed_ mitochondrial-targeted_peptide_drug
HF patients preserved left_ ventricularLV ejection fractionHFpEF echo-Doppler_ studies N-terminal_pro-brain-type natriuretic_peptide
low-volume_ EDs
HABC_battery_ scores health ABC HF_risk_model discriminationnet-reclassification-improvement HF
cardiac_ transplant ECCT patients diabetes mellitus chronic kidney_مرض glomerular_ filtration_rate
construct_ validity self-Care_Maintenance_ Scale RMSEa self-Care_management_ Scale
BAT distance_ walked_distance
preoperative hypoalbuminemia postoperative_normalization albumin_ levels lVAD
rehospitalization acute_myocardial_infarction acute_miocardial_infarction AMI
heart_ failure ischemic nonischemic_ cardiomyopathies pharmacological_armamentarium implantable cardioverter_defibrillators cardiac resynchronization_therapy cardiac_ transplantation left_assist_ devices
SAF PF_performance central_ venous_ pressure sVR_index
admission_median_bNP_levels reduced EF
heart_fail_ admission heart_ трансплантationLV_assist_ device death
LV ejection_fraction velocity circumferential_ shortening maximal systolic_ elastance contractile_ efficiency aCF allopurinol_ rats maximum o2_ consumption_ rate isolated_ cardiomyocytes extracellular_ flux analyzer
HFpEF LV_geometry normal_geometry LV_ hypertrophy relative_wall_ thickness_RWt LVH RWT
angiotensin_ receptor neprilysin_ inhibitor neprilysin_ inhibitor_prodrug angiotensin_ receptor_ antagonist_ valsartan hypertension
blood pressure mitral_plasty degenerative_ MR p3 chordal_ ruptures triangular_reection edge-to-edge_anastomosis ring_ annuloplasty Physio_ Ring
shuttle_ walk_test peak_ oxygen_ uptake echocardiographic N-terminal pro-brain natriuretic_peptide inflammatory_ markers beck_depression_inventory
interaction_term_analyses severely reduced LVEF long-term_ mortality
wstar-Kyoto lean_ ZSF1 obese_ ZSF1 high-fat_Diet euthanization
Kaplan-Meier_ curves log-rank_test risk_ stratification UM/VA/VA-RT_cohorts
multivariate cox_regression_analyses long-standing_ persistent_ AF_type lack_of_ hypertension maintenance_of_ sinus rhythmhazard_ratio
chronic HF-REF NYHA_function_class II eGFR potassium eplerenone wRF
ff ff ff ff ff dual energy_ X-ray_ absorptiometry dXA non-diabetic_ patients chronic_heart_ failure CC non-cachectic CHF myocardial_infarction-both
baseline drug_ dose spironolactone end point_of_ death hospitalization HFhazard_ratio AAs
invasively pulmonary arterial_ hypertension inoperable chronic thromboembolic_ pulmonary_thrombophlebitis impaired right_ventricular_pumps cardiopulmonary_test
cardiovascular_ смерти HF_hospitalization
index_distribution low-volume_ed_cases 30-day_ өлім_all-cause_ readmission high-volume_EDs
implantable cardioverter-defibrillator_deactivation
Cardiac_ magnetic_ resonance left_atrial_area pulmonary_vascular_ resistance
HF_ units systolic left_ ventricular_ejection fraction HF HF New York_ Heart_association
abd_ classification American_ College_of_ Cardiology acc_American_ Heart Association AHA
continuity_equationLV end-diastolic_ volume LV end-systolic_ volume mitral filling flow_flow velocity_ time wave_doppler echocardiography MR mitral_valve plasty
statitistical_ratio all-cause_ mortality sTS HH
HFPSI Ann Arbor Veterans_ Affairs HF_ clinicVA-RT_cohort
non-AAs spironolactone_ dose
preserved_ LVEF haard_ratio preserved_ LVEF
HFpEF HFpEF
echo-derived pulmonary_ arterial_sstolic_ pressure_PASP right_ ventricular tricuspid_ annular_ plane systolic_excursionTAPSe end-systole
severe_CAD electrocardiographic_Q waves left bundle_ branch_ block nondiabetes dyslipidemia hypertension tobacco
receiver_ operating_ characteristic_curve_curve e/e_ ratios PCp
trastuzumab-treated patients coronary_ artery_diameter
LVEF clinical_composite_ response cRT_on cRT_ OFF LV_ end_ systolic_ volume_index
TGF-β signaling tGF-β_ receptor smad small-molecule_ inhibitors c-Kit_cell yield epithelial mesenchymal_ transition_ markers pluripotency_ marker c-Kit_cell differentiation cardiomyocyte-like_cells
HFrEF diuretics co-morbidities NYHA
HF postoperative_echocardiography end-diastolic_ volume_ index LV ejection_fraction MR preserved mitral_valve_ opening mitral_valve_area mean pressure_ gradient
systolic_heart_failure if inhibitor ivabradine_Trial ivabradine echocardiographic
hazard_ratio tpse_ratio tpse_ratio
Chronic_ Kidney_ Epidemiology_collaboration equation glomerular_ filtration_ rate eGFR
paraDIGm-HF stabilized chronic_heart_ failure systolic_ dysfunctionLV_EF functional class NYHA_II-III bNP/NT-pro BNP kardiovascular_ смерть_hospitalization_for_heart_ failure sacubiltril sacubiltril
hyperkalemia African_Americans non-AAs New York_ Heart_association IV HF left_ ventricular_disfunction spironolactone
reverse_ remodeling pre-CRT LV end-diastolic_dimension_index global longitudinal_ strain left_ ventricle left_atrial_area right_ ventricular_velocity
natriuretic_peptide N-terminal pro-B-type natriuretic_peptide N-terminal_pro-b-type_natriuretic_peptide coronary_ artery_ disease b-type natriuretic_peptide natriuretic_peptide N-terminal_ fragment t-proBNP ventricular_ cardiomyocytes ventricular_wall stress myocardial ischemia
iRS1 iRS2 hyperinsulinemia myocardial_ insulin_ resistance cellular_ dysfunction liver-specific IRS2 double-knockout l-dKO
practice-level angiotensin-converting_ enzyme inhibitors_angiotensin_ receptor_blockers interquartile
ivabradine peak early_diastolic_mitral_ flow_velocity peak_ early_diastolic_mitral_ annular_velocity peak_ oxygen_uptake
low-strength evidence liberal_transfusion_ protocols short-term_ mortality_rates aggressive_ protocols acute_ coronary syndrome
risk_of_ death unplanned_ readmission
haek human embryonic_ kidney β1AR downregulation sphingosine-1-phosphate s1PR1_ agonist isoproterenol β-adrenergic_ receptor_ agonist
kansas_city_cardiom_ Questionnaire Minnesota depressive_ symptoms beck_depression_inventory zung_ self-rated_diastolic_function
cardiovascular_ events atrial_ fibrillation left_ ventricular_ejection_fraction diabetes mellitus peripheral_ vascular_ disease myocardial_infarction heart_ failure
in conjunction diastolic_function
disease_risk_ score dRS-stratified_analyses saxagliptin sitagliptin saxagliptin pioglitazone insulin
revascularization coronary_ artery_ bypass_chirurgi hazard ratio percutaneous_ coronary_intervention baseline_ electrocardiogram
biomedical_ treatment CHm left ventricular_ejection_fraction
open-label_ crossover_studies stable heart_ failure patients left_ ventricular_ ejection_fraction arg16/Gln27 gly16/Glu27 β2-receptor carvedilol metoprolol
low-volume_ed_cases high-volume_ED_cases
health_ Buddy_program risk-adjusted all-cause_ mortalityhazard_ratio
multivariable-adjusted_ hazard_ ratios
ctnt NT-probNP aRIC_HF systolic_ blood_ pressure antihypertensive_ medication diabetes prevalent coronary_heart_diameters
eplerenone hyperkalemia renal_function EMPHASIS-HF
low-dose nesiritide 72-hour cumulative_ urine_ volume
standard_care Nordic_ walking_ led to functional_capacity
hyperkalemia wRF diabetes eGFR systolic_ blood_ pressure
PAf biosynthetic_ enzymeslyso-paf acetyl-paf_transferase dithiothreitol dTT-insensitive CDp_ choline 1-alkyl-2-acetyl-sn-glycetyl-sn-sn-glycetyl-sn-sn-sn-glycetyl_ choline_phospho_transferase pf-cpt lipoprotein-associated phospholipa_a2 leukocytes
ivabradine baseline follow-up exercise_capacity peak_energy_uptake peak_ early_diastolic_mitral_velocity
odds_of_ CHF ods_ratio pre-HCT_ chest_ radiation hypertension
baseline NYHA classification
low-dose_ dopamine 72-hour cumulative_ urine volume dopamine
haard_ ratio baseline_ glomerular_ filtration_rate diabetes
peak_ oxygen_ uptake hazard_ratio confidence_ intervals_slope left_ ventricular_ejection_fraction sodium
Kansas City_city_cardiomyopathy_ Questionnaire Beck_depression_inventory zung flow-mediated_dilatation_diameter
